Intervention_type,intervention,Study_count
placebo,placebo,576
Drug,hydroxychloroquine,130
Other,questionnaire,109
Other,standard care,100
Biological,convalescent plasma,92
Drug,standard care,77
Other,no intervention,61
Drug,tocilizumab,46
Drug,ivermectin,43
Drug,azithromycin,40
Drug,remdesivir,39
Drug,favipiravir,35
Drug,enoxaparin,32
Drug,ritonavir,30
Diagnostic Test,pcr,29
Biological,mesenchymal stem cells,26
Drug,lopinavir,26
Biological,blood sample,23
Diagnostic Test,serology test,23
Drug,methylprednisolone,22
Drug,saline,22
Biological,inactivated sars-cov-2 vaccine,20
Drug,colchicine,20
Drug,heparin,20
Drug,lopinavir/ritonavir,19
Drug,nitazoxanide,18
Other,exercise,18
Dietary Supplement,vitamin d,17
Drug,chloroquine,17
Drug,dexamethasone,17
Drug,anakinra,16
Other,blood sample,16
Other,saline,16
Other,survey,16
Drug,interferon,15
Diagnostic Test,igm/igg rapid test,13
Drug,povidone/iodine,13
Other,online survey,13
Behavioral,questionnaire,12
Drug,convalescent plasma,12
Other,observational,12
Other,prone positioning,12
Biological,chadox1,11
Diagnostic Test,blood sample,11
Drug,baricitinib,11
Drug,nitric oxide,11
Drug,ruxolitinib,11
Procedure,prone positioning,11
Procedure,standard care,11
Radiation,radiotherapy,11
Biological,plasma,10
Biological,sars-cov-2 rs,10
Combination Product,azithromycin,10
Drug,vitamin c,10
Other,convalescent plasma,10
Other,covid-19,10
Device,oxygen,9
Diagnostic Test,lung ultrasound,9
Dietary Supplement,vitamin c,9
Drug,camostat mesilate,9
Drug,rivaroxaban,9
Other,data collection,9
Other,telehealth,9
Procedure,blood sample,9
Biological,28-day schedule,8
Biological,bcg,8
Biological,three dose regimen,8
Biological,two dose regimen,8
Device,cellectraâ® 2000,8
Drug,cholecalciferol,8
Drug,hydroxychloroquine / azithromycin,8
Drug,losartan,8
Drug,oseltamivir,8
Other,observation,8
Biological,bnt162b2,7
Biological,saline,7
Diagnostic Test,questionnaire,7
Diagnostic Test,saliva,7
Drug,ace inhibitor,7
Drug,control,7
Drug,povidone-iodine,7
Other,biological samples,7
Other,control,7
Other,exposure,7
Other,quality-of-life assessment,7
Biological,adjuvant,6
Biological,covid-19 vaccine,6
Biological,dose) - stage 1,6
Biological,sars-cov-2 rs/matrix-m1 adjuvant,6
Biological,serology test,6
Combination Product,hydroxychloroquine,6
Diagnostic Test,igg antibody test,6
Diagnostic Test,nasopharyngeal swab,6
Diagnostic Test,rapid test,6
Drug,aspirin,6
Drug,clazakizumab,6
Drug,famotidine,6
Drug,interleukin,6
Drug,mesenchymal stem cells,6
Drug,omega-3,6
Drug,plitidepsin,6
Drug,sarilumab,6
Drug,sofosbuvir,6
Drug,telmisartan,6
Drug,vitamin d,6
Other,best available therapy,6
Behavioral,mindfulness,5
Behavioral,telehealth,5
Biological,ad26.cov2.s,5
Biological,adenovirus type 5 vector,5
Biological,biological,5
Biological,gam-covid-vac,5
Biological,mrna-1273,5
Biological,saliva,5
Diagnostic Test,igg,5
Diagnostic Test,igm,5
Dietary Supplement,zinc,5
Drug,arb,5
Drug,arbidol,5
Drug,camostat,5
Drug,doxycycline,5
Drug,kg,5
Drug,nigella sativa oil,5
Drug,pulmozyme,5
Drug,regn10933,5
Drug,regn10987,5
Drug,zinc,5
Other,interview,5
Other,serology test,5
Behavioral,behavior,4
Behavioral,behavioral intervention,4
Biological,14-day schedule,4
Biological,nk cells,4
Biological,paracetamol,4
Combination Product,hydroxychloroquine / azithromycin,4
Device,mask,4
Drug,anticoagulation,4
Drug,apixaban,4
Drug,atorvastatin,4
Drug,atyr1923,4
Drug,bromhexine hydrochloride,4
Drug,budesonide,4
Drug,canakinumab,4
Drug,ciclesonide,4
Drug,daclatasvir,4
Drug,fluvoxamine,4
Drug,lenzilumab,4
Drug,ly3819253,4
Drug,mavrilimumab,4
Drug,melatonin,4
Drug,nafamostat mesilate,4
Drug,nasal rinse,4
Drug,niclosamide,4
Drug,peginterferon,4
Drug,plasma,4
Drug,sargramostim,4
Drug,thromboprophylaxis,4
Other,ace inhibitor,4
Other,covid-19 pandemic,4
Other,data record,4
Other,normal saline (0.9% sodium chloride solution) - stage 1,4
Other,nutrition,4
Other,other,4
Other,oxygen,4
Procedure,biological samples,4
Procedure,biospecimen collection,4
Procedure,dalargin,4
Procedure,therapeutic plasma exchange (tpe),4
Behavioral,anxiety reduction training,3
Behavioral,behavioral,3
Behavioral,blood donation sms,3
Behavioral,exercise,3
Behavioral,observation,3
Behavioral,prone positioning,3
Behavioral,standard care,3
Biological,ag0302-covid19,3
Biological,bcg-denmark,3
Biological,blood test,3
Biological,bnt162b1,3
Biological,dose)- stage 2,3
Biological,dzif-10c,3
Biological,had5-s-fusion,3
Biological,medium dosage inactivated sars-cov-2 vaccine on a 0-,3
Biological,menacwy,3
Biological,mesenchymalÂ stem cells,3
Biological,mf59 adjuvanted sars-cov-2 sclamp vaccine,3
Biological,standard care,3
Biological,ty027,3
Biological,vpm1002,3
Device,coviage,3
Device,cytosorb,3
Device,vv-ecmo,3
Diagnostic Test,antibody test,3
Diagnostic Test,biological samples,3
Diagnostic Test,blood test,3
Diagnostic Test,breath test,3
Diagnostic Test,chest ct,3
Diagnostic Test,ct-scan,3
Diagnostic Test,elisa,3
Diagnostic Test,flow cytometry,3
Diagnostic Test,igm antibodytest,3
Diagnostic Test,monitoring visit,3
Diagnostic Test,pcr/serology,3
Diagnostic Test,sampling,3
Diagnostic Test,serum test,3
Diagnostic Test,spirometry,3
Diagnostic Test,standard care,3
Diagnostic Test,ultrasound,3
Dietary Supplement,probiotic,3
Dietary Supplement,vitamin super b-complex,3
Drug,1200 mg),3
Drug,acalabrutinib,3
Drug,apixaban 2.5 mg,3
Drug,azd7442,3
Drug,best supportive care,3
Drug,cannabidiol,3
Drug,cenicriviroc,3
Drug,chloroquine/hydroxychloroquine,3
Drug,clopidogrel,3
Drug,corticosteroid,3
Drug,cyclosporine,3
Drug,dalteparin,3
Drug,day,3
Drug,defibrotide,3
Drug,eidd-2801,3
Drug,emtricitabine,3
Drug,fostamatinib,3
Drug,gargle,3
Drug,infliximab,3
Drug,iodine,3
Drug,ly3832479,3
Drug,methylene blue,3
Drug,n-acetylcysteine,3
Drug,naltrexone,3
Drug,opaganib,3
Drug,oxygen,3
Drug,paracetamol,3
Drug,pirfenidone,3
Drug,prednisone,3
Drug,regn10933/regn10987 combination therapy,3
Drug,ribavirin,3
Drug,sevoflurane,3
Drug,sng001,3
Drug,sodium,3
Drug,suspension of heat killed (autoclaved) mycobacterium w,3
Drug,tinzaparin,3
Drug,tofacitinib,3
Other,arb,3
Other,best supportive care,3
Other,blood,3
Other,clinical assessment,3
Other,clinical data,3
Other,exhaled breath sampling,3
Other,kb109,3
Other,non-interventional,3
Other,phone call,3
Other,pulmonary rehabilitation,3
Other,quality of life,3
Other,saliva,3
Other,self supportive care (ssc) alone,3
Other,supportive care,3
Other,taste,3
Other,ultrasound,3
Procedure,oxygen,3
Radiation,phase 2,3
Behavioral,assessment of work-related stress,2
Behavioral,basic feedback,2
Behavioral,control,2
Behavioral,covid-19 symptom monitoring system,2
Behavioral,discussion board for social support,2
Behavioral,education,2
Behavioral,emotional stimulation,2
Behavioral,entrã©e: behavioral skills,2
Behavioral,entrã©e: cognitive skills,2
Behavioral,entrã©e: interpersonal skills,2
Behavioral,expressive writing,2
Behavioral,fear of covid-19 scale,2
Behavioral,information,2
Behavioral,mechanical ventilation,2
Behavioral,motivational interviewing,2
Behavioral,news,2
Behavioral,no intervention,2
Behavioral,ocat,2
Behavioral,online support group,2
Behavioral,personalized feedback,2
Behavioral,simple cognitive task intervention,2
Behavioral,survey,2
Behavioral,video chat,2
Behavioral,views,2
Biological,1 âµg cov2 sam (lnp),2
Biological,10 âµg cov2 sam (lnp),2
Biological,10 to 14 days later,2
Biological,3 âµg cov2 sam (lnp),2
Biological,30 âµg cov2 sam (lnp),2
Biological,adsorbed covid-19 (inactivated) vaccine,2
Biological,ag0301-covid19,2
Biological,allocetra-ots,2
Biological,ampion,2
Biological,angiotensin peptide (1-7) derived plasma,2
Biological,av-covid-19,2
Biological,bacille calmette-guã©rin (bcg),2
Biological,biological data,2
Biological,biological samples,2
Biological,blood collection on their first consultation/10 to 14 days later,2
Biological,brii-196,2
Biological,brii-196/brii-198,2
Biological,brii-198,2
Biological,control,2
Biological,coronavac,2
Biological,ct-p59,2
Biological,cvncov 12 î¼g,2
Biological,cvncov 12î¼g,2
Biological,cvncov 6 î¼g,2
Biological,cvncov vaccine,2
Biological,dose),2
Biological,dose) - stage 2,2
Biological,epivaccorona (epivaccorona vaccine based on peptide antigens for the prevention of covid-19),2
Biological,gbp510 (rbd 25î¼g,2
Biological,gbp510 adjuvanted with alum (rbd 10î¼g,2
Biological,gbp510 adjuvanted with alum (rbd 25î¼g,2
Biological,gbp510 adjuvanted with as03 (rbd 10î¼g,2
Biological,gbp510 adjuvanted with as03 (rbd 25î¼g,2
Biological,had5-s-fusion/n-etsd vaccine,2
Biological,high-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years),2
Biological,high-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years),2
Biological,high dosage inactivated sars-cov-2 vaccine,2
Biological,human amniotic fluid,2
Biological,intramuscular vaccine,2
Biological,lenzilumab,2
Biological,longitudinally,2
Biological,low-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years),2
Biological,low-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years),2
Biological,medium dosage inactivated sars-cov-2 vaccine,2
Biological,medium dosage inactivated sars-cov-2 vaccine on a 0-/28-day schedule,2
Biological,moderna covid-19 vaccine,2
Biological,n-etsd vaccine,2
Biological,oral polio vaccine,2
Biological,pcr,2
Biological,plx-pad,2
Biological,qazcovid-inâ®-vaccine against covid-19,2
Biological,qazcovid-inâ® - covid-19 inactivated vaccine,2
Biological,recombinant new coronavirus vaccine (cho cell) low-dose group,2
Biological,recombinant new coronavirus vaccine (cho cells) high-dose group,2
Biological,saline containing 1% human serum albuminï¼ˆsolution without uc-mscsï¼‰,2
Biological,serum test,2
Biological,stool collection,2
Biological,two dose chadox1 ncov-19,2
Biological,"two doses of low dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",2
Biological,"two doses of medium dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",2
Biological,ub-612,2
Biological,vir-7831,2
Combination Product,,2
Combination Product,- tocilizumab,2
Combination Product,atazanavir,2
Combination Product,cospherunate,2
Combination Product,hyperbaric oxygen,2
Combination Product,na-831,2
Combination Product,standard care,2
Device,aeonose,2
Device,citrox,2
Device,cpap,2
Device,ct-scan,2
Device,cytokine adsorption,2
Device,ðžxygen therapy,2
Device,extracorporeal blood purification using the oxirisâ® (an69st) hemofilter,2
Device,fit test,2
Device,gammacoreâ® (vagus nerve stimulation),2
Device,gammacoreâ® sapphire (non-invasive vagus nerve stimulator),2
Device,high flow nasal cannula,2
Device,high flow nasal cannula (hfnc),2
Device,hyperbaric oxygen,2
Device,"ib10 sphingotestâ® bio-admâ® apparatus (sphingotec gmbh, hennigsdorf, germany)",2
Device,impulseâ„¢ una e-stethoscope,2
Device,ion mobility spectrometry (ims),2
Device,life2000â® ventilator,2
Device,lucira covid-19 all-in-one test kit,2
Device,"magpro x100 stimulator, b70 fluid-cooled coil",2
Device,marker therapeutics d2000 cartridge (d2000) for use with the spectra optiaâ® apheresis system (optia spd protocol),2
Device,metanebâ® system,2
Device,nä°cas,2
Device,nasal rinse,2
Device,nioâ® (intraosseous access),2
Device,nitric oxide delivered via lungfitâ„¢ system,2
Device,seraphâ®-100 microbindâ® affinity blood filter,2
Device,smf,2
Device,splenic ultrasound,2
Device,volatile organic compounds analysis,2
Diagnostic Test,cag,2
Diagnostic Test,conjunctival swab,2
Diagnostic Test,coronary angiography,2
Diagnostic Test,covid-19 antigen,2
Diagnostic Test,covid-viroâ® test,2
Diagnostic Test,drã¤ger antigen test sars-cov-2,2
Diagnostic Test,ecg,2
Diagnostic Test,echocardiography,2
Diagnostic Test,exercise,2
Diagnostic Test,id nowâ„¢ covid-19 screening test,2
Diagnostic Test,igg test,2
Diagnostic Test,interleuken 6,2
Diagnostic Test,mri,2
Diagnostic Test,muscle,2
Diagnostic Test,nanomix elabâ® covid-19 rapid antigen panel (non-interventional),2
Diagnostic Test,nasal,2
Diagnostic Test,online survey,2
Diagnostic Test,performance evaluation,2
Diagnostic Test,pulmonary function tests,2
Diagnostic Test,rapid diagnostic test vs pcr,2
Diagnostic Test,sample collection,2
Diagnostic Test,sars-cov-2,2
Diagnostic Test,testing,2
Dietary Supplement,300 mg of omega3-fa,2
Dietary Supplement,aã§aã­ palm berry extract - natural product,2
Dietary Supplement,asbrip,2
Dietary Supplement,bioargininaâ®,2
Dietary Supplement,glycine,2
Dietary Supplement,quercetin,2
Dietary Supplement,rhea health toneâ®,2
Dietary Supplement,sivomixx,2
Dietary Supplement,viusid,2
Drug,[18f]f-arag (2'-deoxy-2'-fluoro-9-î²-d-arabinofuranosylguanine),2
Drug,100 mg,2
Drug,18f-î±vî²6-bp,2
Drug,acetylsalicylic acid,2
Drug,activase,2
Drug,"alpha-interferon, abidol, ribavirin, buzhong yiqi plus",2
Drug,ambrisentan,2
Drug,antibiotics,2
Drug,antihypertensives,2
Drug,apremilast,2
Drug,artecomâ® (pyronaridine-artesunate),2
Drug,at-527,2
Drug,avigan,2
Drug,bacille calmette-guã©rin (bcg),2
Drug,bamlanivimab,2
Drug,bat,2
Drug,bcg,2
Drug,bemiparin,2
Drug,best available therapy,2
Drug,bevacizumab,2
Drug,brequinar,2
Drug,broncho-vaxomâ®,2
Drug,bucillamine,2
Drug,chlorhexidine,2
Drug,clorhexidine dental phbâ©,2
Drug,cobicistat,2
Drug,"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,",2
Drug,corticosteroids,2
Drug,curosurfâ® (poractant alfa),2
Drug,cyt107,2
Drug,dapagliflozin,2
Drug,darunavir,2
Drug,darunavir/cobicistat,2
Drug,dipyridamole,2
Drug,distilled water,2
Drug,dornase alfa,2
Drug,doxycycline tablets,2
Drug,duvelisib,2
Drug,early-dexamethasone,2
Drug,edp1815,2
Drug,essential oils,2
Drug,exo 1 inhalation,2
Drug,exo 2 inhalation,2
Drug,folic acid,2
Drug,fondaparinux,2
Drug,fuzheng huayu,2
Drug,group hydroxychloroquine,2
Drug,guduchi ghan vati,2
Drug,gx-i7,2
Drug,honey,2
Drug,hormones,2
Drug,hydroxychloroquine/clindamycin/primaquine,2
Drug,hzvsf-v13,2
Drug,ibrutinib,2
Drug,ibuprofen,2
Drug,iloprost,2
Drug,imatinib,2
Drug,immunoglobulin,2
Drug,imu-838,2
Drug,ino-4800,2
Drug,interferon-ãÿ-1a,2
Drug,interferon-î² 1a,2
Drug,interferon î²-1b,2
Drug,iota-carrageenan,2
Drug,ledipasvir,2
Drug,leflunomide,2
Drug,lopinavir/ ritonavir,2
Drug,m5049,2
Drug,maraviroc,2
Drug,"minus formula, huhuang detoxicity paste, baimu qingre jiedu paste",2
Drug,molnupiravir,2
Drug,n-acetyl cysteine,2
Drug,na-831,2
Drug,nusepinâ® 0.1 mg,2
Drug,nusepinâ® 0.2 mg,2
Drug,omegavenâ®,2
Drug,osoc,2
Drug,oximenâ® 3%,2
Drug,pegylated interferon-î±2b,2
Drug,proxalutamide,2
Drug,pul-042,2
Drug,pyronaridine-artesunate,2
Drug,ravulizumab,2
Drug,recombinant human interferon î±2b spray,2
Drug,regn10933 / regn10987,2
Drug,ribaroxaban,2
Drug,rivaroxaban 10 mg,2
Drug,roactemra,2
Drug,rosuvastatin,2
Drug,rtb101,2
Drug,ruconest,2
Drug,sedation,2
Drug,selinexor,2
Drug,silmitasertib,2
Drug,siltuximab,2
Drug,silymarin,2
Drug,sirolimus,2
Drug,soc / placebo,2
Drug,sodium bicarbonate,2
Drug,sofosbuvir/daclatasvir,2
Drug,sofosbuvir/ledipasvir,2
Drug,standard covid-19 care,2
Drug,supportive care,2
Drug,tacrolimus,2
Drug,td-0903,2
Drug,tenofovir disoproxil,2
Drug,thymalfasin,2
Drug,tinzaparin/dalteparin,2
Drug,tricorâ® 145mg tablets,2
Drug,virazole,2
Drug,vitis xtra forteâ©,2
Drug,zilucoplanâ®,2
Other,acute kidney injury,2
Other,ayurveda,2
Other,blood test,2
Other,brescä°a-covä°d respiratory severity scale,2
Other,canine odor detection of volatile organic compounds,2
Other,caring contacts,2
Other,continuation of arb,2
Other,covid-19 infection,2
Other,covid-19 patients,2
Other,ct-scan,2
Other,data extraction from medical files,2
Other,diagnosed with covid-19,2
Other,diagnostic laboratory biomarker analysis,2
Other,dialysis,2
Other,discontinuation of arb,2
Other,education,2
Other,electronic health record review,2
Other,exercise/nutrition,2
Other,file scanning,2
Other,health supplements,2
Other,icu treatment,2
Other,immunological,2
Other,indicators of central sensitisation,2
Other,ivermectin,2
Other,kb109 / self supportive care (ssc),2
Other,meditation (1 x 20-minute guided audio training),2
Other,normal saline (0.9% sodium chloride solution)- stage 2,2
Other,nosocomial,2
Other,online questionnaires,2
Other,oxygen-ozone,2
Other,patient-reported online questionnaire on olfactory,2
Other,patient-reported online questionnaire on olfactory/taste disturbances,2
Other,physiotherapy,2
Other,plasma,2
Other,practice details,2
Other,pregnant women with laboratory-confirmed 2019-n-cov,2
Other,qualitative approaches to analysis,2
Other,recop unit patient,2
Other,retrospective data collection,2
Other,sample collection,2
Other,sars-cov2 infection,2
Other,self supportive care (ssc),2
Other,serum test,2
Other,stp,2
Other,surgical mask,2
Other,t-detectâ„¢ sars-cov-2 assay,2
Other,taste disturbances,2
Other,tele-yoga,2
Other,teleconsultation either by phone,2
Other,vehicle control,2
Other,yoga,2
placebo,high-dose placebo (18-59 years),2
placebo,high-dose placebo (60-85 years),2
placebo,low-dose placebo (18-59 years),2
placebo,low-dose placebo (60-85 years),2
placebo,placebo (normal saline solution),2
placebo,"three doses of placebo at the schedule of day 0, 14, 28ï¼ˆhigh-dose groupï¼‰",2
placebo,"two doses of placebo at the schedule of day 0, 28ï¼ˆhigh-dose groupï¼‰",2
placebo,"two doses of placebo at the schedule of day 0, 28ï¼ˆmiddle-dose groupï¼‰",2
Procedure,convalescent plasma,2
Procedure,laryngoscopy,2
Procedure,ophthalmologic exam,2
Procedure,pcr,2
Procedure,throat swab,2
Radiation,low,2
Radiation,phase 1,2
Behavioral,,1
Behavioral,a $10 survey incentive,1
Behavioral,a $20 survey incentive,1
Behavioral,acknowledgement racial injustice ama,1
Behavioral,action (tara),1
Behavioral,active control:healthy living,1
Behavioral,african american sender acknowledgement,1
Behavioral,african american sender in informational videos.,1
Behavioral,ama acknowledgement drug pricing,1
Behavioral,assigned strategies: active choice,1
Behavioral,assigned strategies: enhanced active choice,1
Behavioral,assigned strategies: opt-in,1
Behavioral,attention bias modification (abm),1
Behavioral,audio for relaxation techniques,1
Behavioral,augmented message,1
Behavioral,award,1
Behavioral,award advice,1
Behavioral,award/covid-specific advice,1
Behavioral,bandebereho fathers',1
Behavioral,behavioral activation ssi,1
Behavioral,behavioral economics,1
Behavioral,behavioral/cognitive assessment,1
Behavioral,behaviour change technique intervention to improve quality of life,1
Behavioral,best message,1
Behavioral,best message / augmented message/implementation strategy,1
Behavioral,best message alone,1
Behavioral,biobehavioral tele-rehabilitation sessions,1
Behavioral,breast feeding adherence,1
Behavioral,brief counseling,1
Behavioral,brief informational infographic,1
Behavioral,brief interpersonal telepsychotherapy,1
Behavioral,brief mindfulness based intervention,1
Behavioral,brief skills for safer living,1
Behavioral,burnout,1
Behavioral,"change in knowledge, motivation, skills, resources",1
Behavioral,change in preference to surgery under covid-19 pandemic.,1
Behavioral,chat-based instant messaging support,1
Behavioral,chat-based support,1
Behavioral,choice of assignment: active choice,1
Behavioral,choice of assignment: enhanced active choice,1
Behavioral,choice of assignment: opt-in,1
Behavioral,clinical features,1
Behavioral,co-mestring (co-coping),1
Behavioral,cognitive,1
Behavioral,cognitive activity,1
Behavioral,cognitive assessment,1
Behavioral,cognitive behavioral brief-telepsychotherapy,1
Behavioral,collection of odour samples,1
Behavioral,combination,1
Behavioral,communication,1
Behavioral,"community-based, mobile van testing",1
Behavioral,comparison group,1
Behavioral,compass,1
Behavioral,contain covid anxiety ssi,1
Behavioral,controls,1
Behavioral,cosh self-help smoking cessation booklet,1
Behavioral,cost-benefit frame,1
Behavioral,counselling,1
Behavioral,"couple hopes guided, internet-delivered, self-help intervention",1
Behavioral,couples' group education,1
Behavioral,covid-19,1
Behavioral,covid-19 infection will be conducted.,1
Behavioral,covid-19 positive pregnant women,1
Behavioral,covid-19 related health warning leaflet,1
Behavioral,covid-specific advice,1
Behavioral,covid-surgres questionaire,1
Behavioral,crisis intervention therapy,1
Behavioral,critical dialogue,1
Behavioral,current clinical practices of participating physicians,1
Behavioral,daily coping toolkit,1
Behavioral,daily monitoring,1
Behavioral,data collection,1
Behavioral,data registry,1
Behavioral,decisions of limitations,1
Behavioral,decisions of limitations/stop processing,1
Behavioral,desmond,1
Behavioral,dialectical behavioral therapy (dbt) skills,1
Behavioral,digital brochure,1
Behavioral,digital health online platform,1
Behavioral,digital problem solving tool,1
Behavioral,digital social activity video intervention,1
Behavioral,discussion board for social support /basic feedback,1
Behavioral,discussion board for social support/personalized feedback,1
Behavioral,duty frame,1
Behavioral,early access,1
Behavioral,early rehabilitation,1
Behavioral,eating habits,1
Behavioral,edinburgh postnatal depression scale,1
Behavioral,education sessions,1
Behavioral,educational meetings/visual prompts,1
Behavioral,educational video,1
Behavioral,ei open ended pre-survey,1
Behavioral,ei open ended pre-survey/semi structured interview,1
Behavioral,emdr,1
Behavioral,emotion regulation training via telehealth,1
Behavioral,emotional freedom technique,1
Behavioral,emotional support plan,1
Behavioral,emphasis of academic researchers involvement,1
Behavioral,emphasis of government involvement,1
Behavioral,enhanced follow through message,1
Behavioral,enhanced hygiene measures,1
Behavioral,enriched survey feedback,1
Behavioral,environmental exposure,1
Behavioral,environmental exposure/clinical features,1
Behavioral,ethnic frame,1
Behavioral,evaluation,1
Behavioral,examine the impact of covid-19 during pregnancy,1
Behavioral,exercise training,1
Behavioral,experiences of health care professionals working in intensive care units during the covid-19 pandemic,1
Behavioral,experimental group,1
Behavioral,face mask awareness,1
Behavioral,family nurture intervention (fni),1
Behavioral,fixed site standard of care testing,1
Behavioral,focused,1
Behavioral,focused/targeted message,1
Behavioral,fresh start,1
Behavioral,fsfi survey,1
Behavioral,gamification,1
Behavioral,general communication message,1
Behavioral,general health education,1
Behavioral,general recommendation,1
Behavioral,generalized anxiety disorder-7 (gad-7),1
Behavioral,generic best practices,1
Behavioral,geneva emotional competence test (geco),1
Behavioral,growth mindset ssi,1
Behavioral,guided online support program,1
Behavioral,hads,1
Behavioral,handwashing stations at the public places,1
Behavioral,health care worker survey,1
Behavioral,health literacy,1
Behavioral,health warning leaflet,1
Behavioral,healthcare providers' communication about the covid-19 vaccine,1
Behavioral,healthy minds program foundations training,1
Behavioral,high intensity interval training,1
Behavioral,high touch multi-pronged behavioral intervention,1
Behavioral,hiking challenge,1
Behavioral,home-based exercise training,1
Behavioral,hope intervention,1
Behavioral,hospital anxiety depression measure,1
Behavioral,hospital: dd-ca,1
Behavioral,hospital: usual care (uc),1
Behavioral,immediate vs. delayed provision of antibody test results,1
Behavioral,implementation strategy,1
Behavioral,in-person instruction,1
Behavioral,in-person postoperative visit,1
Behavioral,informational sheet,1
Behavioral,informational videos,1
Behavioral,informational videos/social media campaigns encouraging cancer screening.,1
Behavioral,instrumental activities of daily living shaping,1
Behavioral,insurance navigation,1
Behavioral,intermittent,1
Behavioral,internet-based cognitive behavioral therapy,1
Behavioral,internet-based guided self-help based on cbt principles,1
Behavioral,internet-based self-help,1
Behavioral,internet-based self-help after 3 weeks,1
Behavioral,internet-delivered cognitive behavior therapy (icbt) for dysfunctional worry related to the covid-19 pandemic,1
Behavioral,intervention app,1
Behavioral,intervention group coronacope,1
Behavioral,intervention program,1
Behavioral,interview,1
Behavioral,"knowledge, attitude, practice, awareness, preference",1
Behavioral,kundalini yoga,1
Behavioral,kundalini yoga/anxiety reduction training,1
Behavioral,lay telephone coaching,1
Behavioral,lifestyle (exercise),1
Behavioral,lifestyle (meditation),1
Behavioral,lifestyle change promotion program,1
Behavioral,lift,1
Behavioral,lock-down,1
Behavioral,lock-down/social distancing,1
Behavioral,loneliness in the covid-19 environment.,1
Behavioral,maslach burnout inventory (mbi),1
Behavioral,medication review,1
Behavioral,meditation,1
Behavioral,meditation app usage,1
Behavioral,meditation/anxiety reduction training,1
Behavioral,mencare,1
Behavioral,mencare//bandebereho fathers'/couples' group education,1
Behavioral,mental imagery,1
Behavioral,mental well-being,1
Behavioral,messaging,1
Behavioral,mhealth platform,1
Behavioral,mindfullness training,1
Behavioral,mindfulness-based cognitive therapy,1
Behavioral,mindfulness-based stress reduction,1
Behavioral,mindfulness session(s),1
Behavioral,mindfulness training,1
Behavioral,minimal attention control intervention,1
Behavioral,mobile mental health app - 1,1
Behavioral,mobile mental health app - 2,1
Behavioral,mobile mental health app - 3,1
Behavioral,mobile mental health app - 4,1
Behavioral,motivational interviewing/covid-19 symptom monitoring system,1
Behavioral,muscle relaxation therapy,1
Behavioral,navigation services,1
Behavioral,neurocognitive assessment,1
Behavioral,no activities of the hbcc project,1
Behavioral,no instruction regarding positioning,1
Behavioral,no messaging,1
Behavioral,no racial inequality highlighting,1
Behavioral,non-mindfulness intervention,1
Behavioral,nudge,1
Behavioral,occupational health workers,1
Behavioral,online instruction,1
Behavioral,online intervention grief covid-19,1
Behavioral,online intervention mental health covid-19,1
Behavioral,online kkh sports singapore program with usual care,1
Behavioral,online lifestyle intervention,1
Behavioral,online survey,1
Behavioral,opt-in recruitment email,1
Behavioral,opt-out recruitment email,1
Behavioral,parentchat for parents of children ages 2-17,1
Behavioral,participate in a massive musical event,1
Behavioral,patient-centred advice on telephone consultation in tb patients:,1
Behavioral,patient educational video,1
Behavioral,patient mychart scheduling link,1
Behavioral,peer resilience champion,1
Behavioral,peer support,1
Behavioral,personal protective measures,1
Behavioral,personalized ambulatory training,1
Behavioral,personalized health education,1
Behavioral,physical,1
Behavioral,physical/cognitive activity,1
Behavioral,position,1
Behavioral,positive feedback,1
Behavioral,post-intensive care unit syndrome,1
Behavioral,prayer,1
Behavioral,preventive information,1
Behavioral,problem-solving,1
Behavioral,problem-solving/relationship improvement intervention.,1
Behavioral,progressive muscle relaxation,1
Behavioral,promotores de salud,1
Behavioral,prosocial-benefit,1
Behavioral,psychological,1
Behavioral,psychological triaging intervention,1
Behavioral,psychological/behaviour change support,1
Behavioral,psychotherapy,1
Behavioral,ptsd,1
Behavioral,questionnaire : preparedness for caregiving scale,1
Behavioral,racial,1
Behavioral,racial inequality highlighted,1
Behavioral,racial/ethnic frame,1
Behavioral,reading a book,1
Behavioral,recharge,1
Behavioral,referral,1
Behavioral,referral card,1
Behavioral,referral/digital brochure,1
Behavioral,reframing,1
Behavioral,registery data collection,1
Behavioral,rehabilitation,1
Behavioral,relationship improvement intervention.,1
Behavioral,relaxation,1
Behavioral,remain covid free ssi,1
Behavioral,remote cognitive behavioral therapy for insomnia,1
Behavioral,remote problem management plus,1
Behavioral,remote pulmonary rehabilitation,1
Behavioral,resilience program,1
Behavioral,resistance training,1
Behavioral,reward re-training,1
Behavioral,routine psychological support,1
Behavioral,saliva,1
Behavioral,sampler skills,1
Behavioral,scarcity message,1
Behavioral,self-benefit,1
Behavioral,self-care tools,1
Behavioral,"self-collected, home-based testing",1
Behavioral,self-compassion for chronic pain virtual group treatment program,1
Behavioral,self-help booklet,1
Behavioral,self-management booklet (switch: stay well during covid-19),1
Behavioral,self-questionnary,1
Behavioral,self study,1
Behavioral,semi-directive interview,1
Behavioral,semi structured interview,1
Behavioral,services as usual,1
Behavioral,shared decision making,1
Behavioral,shg,1
Behavioral,simha kriya,1
Behavioral,simple cognitive task,1
Behavioral,simulation intervention,1
Behavioral,sm-ema,1
Behavioral,smell training,1
Behavioral,sms-based support,1
Behavioral,sms message support,1
Behavioral,social distancing,1
Behavioral,social media,1
Behavioral,social media campaigns encouraging cancer screening.,1
Behavioral,social media/news consumption,1
Behavioral,social proof,1
Behavioral,socialization,1
Behavioral,speed of processing training,1
Behavioral,sse educational intervention,1
Behavioral,standard charity resources,1
Behavioral,stigma awareness video intervention,1
Behavioral,stop processing,1
Behavioral,stress first aid,1
Behavioral,subacute rehabilitation,1
Behavioral,supportive therapy,1
Behavioral,supportive therapy ssi,1
Behavioral,tailored best practices,1
Behavioral,tailored recommendations,1
Behavioral,targeted message,1
Behavioral,technology based social interactions,1
Behavioral,tele-delivered psychological intervention,1
Behavioral,tele-interventions related to diabetes management,1
Behavioral,tele-interventions related to diabetes management/mental well-being,1
Behavioral,telehealth/counselling,1
Behavioral,telemedicine visit,1
Behavioral,telepsychoeducation,1
Behavioral,telepsychoeducation with personalized videos,1
Behavioral,telepsychoeducation without personalized videos,1
Behavioral,telesimulation,1
Behavioral,text material for psychoeducation,1
Behavioral,text material for psychoeducation/audio for relaxation techniques,1
Behavioral,the psychosocial effects of covid-19 pandemic on dental professionals,1
Behavioral,therapy intervention,1
Behavioral,"training for awareness, resilience,",1
Behavioral,"training for awareness, resilience,/action (tara)",1
Behavioral,training session adressing information,1
Behavioral,training session adressing information/health literacy,1
Behavioral,"training video on anxiety, fear",1
Behavioral,"training video on anxiety, fear/loneliness in the covid-19 environment.",1
Behavioral,transcendental meditation,1
Behavioral,transfer package from ci therapy,1
Behavioral,trauma-informed yoga video recording,1
Behavioral,trauma informed psychotherapy,1
Behavioral,trauma informed yoga,1
Behavioral,trier social stress test,1
Behavioral,turkish physicians,1
Behavioral,ultra brief online mindfulness-based intervention,1
Behavioral,unavailable covid test result - hypothetical scenario,1
Behavioral,unified protocol for covid-19 parenting stress (up-covid),1
Behavioral,use of social media during covid-19,1
Behavioral,usual care positioning with no instructions,1
Behavioral,video chat / basic feedback,1
Behavioral,video chat /personalized feedback,1
Behavioral,virtual-care cognitive behavioural therapy,1
Behavioral,virtual elm,1
Behavioral,virtual family-based treatment,1
Behavioral,virtual group exercise,1
Behavioral,virtual group intervention,1
Behavioral,visual prompts,1
Behavioral,vr for psychoeducation,1
Behavioral,vr for psychoeducation/relaxation,1
Behavioral,web based questionnaire,1
Behavioral,wellness education,1
Behavioral,white sender in acknowledgement,1
Behavioral,white sender in informational videos,1
Behavioral,who recommendations (waiting condition),1
Behavioral,written summary of rounds,1
Behavioral,yoga group,1
Biological,0.5ml,1
Biological,15mg,1
Biological,2.2x10^10vp (qpcr) boost,1
Biological,21 - phase 2,1
Biological,28),1
Biological,2nd dose),1
Biological,"a high-dose recombinant covid-19 vaccine (cho cell) (18-59 years) at the schedule of day 0, 28, 56",1
Biological,"a high-dose recombinant covid-19 vaccine (cho cell) (60-85 years) at the schedule of day 0, 28, 56",1
Biological,"a middle-dose recombinant covid-19 vaccine (cho cell) (18-59 years) at the schedule of day 0, 28, 56",1
Biological,"a middle-dose recombinant covid-19 vaccine (cho cell) (60-85 years) at the schedule of day 0, 28, 56",1
Biological,aapc,1
Biological,abatacept,1
Biological,ad5-ncov,1
Biological,adcld-cov19,1
Biological,adcovid,1
Biological,adenovirus type-5 vectored covid-19 vaccine,1
Biological,adimrsc-2f,1
Biological,administration of equine immunoglobulin anti sars-cov-2,1
Biological,adsorbed sars-cov-2 (inactivated) vaccine,1
Biological,aldesleukin,1
Biological,alum adjuvant,1
Biological,aluminum adjuvant of inactivated sars-cov-2 vaccine,1
Biological,anakinra,1
Biological,anti-cd14,1
Biological,anti-coronavirus antibodies (immunoglobulins)obtained with dfpp from convalescent patients,1
Biological,anti-sars-cov-2 igt seropositivity,1
Biological,arct-021 dose 1,1
Biological,arct-021 dose 2,1
Biological,arct-021 dose 3,1
Biological,arct-021 dose 4,1
Biological,arct-021 dose regimen 1,1
Biological,arct-021 dose regimen 2,1
Biological,arct-021 single dose priming,1
Biological,arct-021 two higher dose priming,1
Biological,arct-021 two lower dose priming,1
Biological,asunercept,1
Biological,autologous non-hematopoietic peripheral blood stem cells (nhpbsc),1
Biological,avdoralimab,1
Biological,azd1222,1
Biological,azd7442,1
Biological,azd7442 (im),1
Biological,azd7442 (iv),1
Biological,bactek-r,1
Biological,bactrl-spike,1
Biological,bamlanivimab,1
Biological,bbv152,1
Biological,bbv152a - phase i,1
Biological,bbv152a - phase ii,1
Biological,bbv152b - phase i,1
Biological,bbv152b - phase ii,1
Biological,bbv152c - phase i,1
Biological,bbv154 vaccine,1
Biological,best available therapy,1
Biological,biological assays in particular on the lipid metabolism,1
Biological,biological test,1
Biological,biological/vaccine: recombinant new coronavirus vaccine (cho cell) low-dose group,1
Biological,biological/vaccine: recombinant new coronavirus vaccine (cho cells) high-dose group,1
Biological,biological/vaccine: recombinant new coronavirus vaccine (cho cells) placebo group,1
Biological,biological: mrna-1273,1
Biological,bnt162a1,1
Biological,bnt162b2 mrna covid-19 vaccine,1
Biological,bnt162b3,1
Biological,bnt162c2,1
Biological,boost,1
Biological,c-135-ls,1
Biological,c144-ls,1
Biological,c144-ls/c-135-ls,1
Biological,cap-1002,1
Biological,castem,1
Biological,ccp,1
Biological,cell therapy protocol 1,1
Biological,cell therapy protocol 2,1
Biological,cellular immune response after anti-sars-cov-2 vaccine administration,1
Biological,chadox1 ncov-19 0.5ml (3.5-6.5x10^10vp) late vaccine (lv),1
Biological,chadox1 ncov-19 0.5ml (3.5-6.5x10^10vp) late vaccine two (lvt),1
Biological,chadox1 ncov-19 single dose,1
Biological,chadox1 ncov-19 single dose / paracetamol,1
Biological,chadox1 ncov-19 two dose,1
Biological,chadox1 ncov-19 two dose / paracetamol,1
Biological,chadv68-s,1
Biological,chadv68-s-tce,1
Biological,chest ct,1
Biological,ck0802,1
Biological,comirnaty - biontech manufacturing gmbh,1
Biological,"comirnaty (covid-19, mrna vaccine)",1
Biological,convalescent plasma infusion,1
Biological,convalescent plasma/standard care,1
Biological,convp,1
Biological,covi-vac,1
Biological,covid-19,1
Biological,covid-19 vaccine astrazeneca suspension for injection,1
Biological,covid-19 vaccine moderna dispersion for injection - moderna biotech,1
Biological,covid-evax,1
Biological,covid-higiv,1
Biological,covid vaccines,1
Biological,covid19 vaccine,1
Biological,covishield,1
Biological,covishield 0.25ml,1
Biological,covishield 0.5ml,1
Biological,coviv,1
Biological,coviv only (1st,1
Biological,coviv only (1st/2nd dose),1
Biological,coviv/iiv4; coviv/ppv23,1
Biological,csl760,1
Biological,ct-p59/placebo,1
Biological,cvncov,1
Biological,cyp-001,1
Biological,dose finding phase (mtd),1
Biological,ds-5670a,1
Biological,emapalumab,1
Biological,erucov-vac,1
Biological,eucorvac-19,1
Biological,exposure,1
Biological,exposure to covid-19,1
Biological,f-652,1
Biological,ffp,1
Biological,flu shot,1
Biological,gam-covid-vac lyo,1
Biological,gamunex-c,1
Biological,"garadacimab, factor xiia antagonist monoclonal antibody",1
Biological,gbp510 (rbd 10î¼g,1
Biological,gbp510 (rbd 10î¼g/dose) - stage 1,1
Biological,gbp510 (rbd 25î¼g/dose)- stage 2,1
Biological,gbp510 (rbd 25î¼g/dose) - stage 1,1
Biological,gbp510 adjuvanted with alum (rbd 10î¼g/dose) - stage 1,1
Biological,gbp510 adjuvanted with alum (rbd 10î¼g/dose) - stage 2,1
Biological,gbp510 adjuvanted with alum (rbd 25î¼g/dose)- stage 2,1
Biological,gbp510 adjuvanted with alum (rbd 25î¼g/dose) - stage 1,1
Biological,gbp510 adjuvanted with as03 (rbd 10î¼g/dose) - stage 1,1
Biological,gbp510 adjuvanted with as03 (rbd 10î¼g/dose) - stage 2,1
Biological,gbp510 adjuvanted with as03 (rbd 25î¼g/dose)- stage 2,1
Biological,gbp510 adjuvanted with as03 (rbd 25î¼g/dose) - stage 1,1
Biological,gc5131,1
Biological,gls-5310,1
Biological,grad-cov2,1
Biological,group a (ag0302-covid19),1
Biological,group b (ag0302-covid19),1
Biological,had5-s-fusion/n-etsd (suspension for injection),1
Biological,heparin,1
Biological,hepatitis a vaccine,1
Biological,high-dose placebo (18-59 years)/three dose regimen,1
Biological,high-dose placebo (18-59 years)/two dose regimen,1
Biological,high-dose placebo (60-85 years)/three dose regimen,1
Biological,high-dose placebo (60-85 years)/two dose regimen,1
Biological,high-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years)/three dose regimen,1
Biological,high-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years)/two dose regimen,1
Biological,high-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years)/three dose regimen,1
Biological,high-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years)/two dose regimen,1
Biological,high dose of kbp-covid-19,1
Biological,hiv,1
Biological,hmsc,1
Biological,iibr-100 high-dose (prime),1
Biological,iibr-100 low-dose (prime-boost),1
Biological,iibr-100 medium dose (prime),1
Biological,"iibr-100, low dose (prime)",1
Biological,iiv4 for the 1st dose,1
Biological,iiv4 for the 1st dose/ppv23 for the 2nd dose,1
Biological,iiv4; coviv,1
Biological,imm-101,1
Biological,immune globulin,1
Biological,immune plasma,1
Biological,immunoglobulin,1
Biological,inactivated sars cov 2 vaccine (vero cell). wuhan,1
Biological,inactivated vaccine,1
Biological,information,1
Biological,injection,1
Biological,injection of secretome-mscs,1
Biological,ino-4800,1
Biological,interferon,1
Biological,ixekizumab,1
Biological,kamada anti-sars-cov-2,1
Biological,kg eb05 iv,1
Biological,kg),1
Biological,kg;100mg,1
Biological,kg;50mg,1
Biological,lanadelumab,1
Biological,licensed seasonal influenza vaccine,1
Biological,liquid alpha1-proteinase inhibitor (human),1
Biological,longeveron mesenchymal stem cells (lmscs),1
Biological,low,1
Biological,low-dose placebo (18-59 years)/three dose regimen,1
Biological,low-dose placebo (18-59 years)/two dose regimen,1
Biological,low-dose placebo (60-85 years)/three dose regimen,1
Biological,low-dose placebo (60-85 years)/two dose regimen,1
Biological,low-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years)/three dose regimen,1
Biological,low-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years)/two dose regimen,1
Biological,low-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years)/three dose regimen,1
Biological,low-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years)/two dose regimen,1
Biological,low dose of kbp-covid-19,1
Biological,low/upper respiratory tract sample,1
Biological,lv-smenp-dc vaccine,1
Biological,lv-smenp-dc vaccine/antigen-specific ctls,1
Biological,ly3819253,1
Biological,matrix-m1 adjuvant (crossover vaccination period),1
Biological,matrix-m1 adjuvant (initial vaccination period),1
Biological,matrix m1-adjuvant,1
Biological,medium dosage inactivated sars-cov-2 vaccine on a 0-/14-day schedule,1
Biological,menacwy prime,1
Biological,menacwy prime/saline placebo boost / paracetamol,1
Biological,menacwy single dose,1
Biological,menacwy single dose / paracetamol,1
Biological,menacwy vaccine,1
Biological,mesenchymalÂ stem cells/heparin,1
Biological,mesencure,1
Biological,microbiome spray,1
Biological,mon002,1
Biological,mrna-1273.351,1
Biological,mrna-1283,1
Biological,msc,1
Biological,multipeptide cocktail,1
Biological,multistem,1
Biological,mva-sars-2-s vaccinations (days 0,1
Biological,mva-sars-2-s vaccinations (days 0/28),1
Biological,mvc-cov1901,1
Biological,mvc-cov1901(s protein with adjuvant),1
Biological,mvc-cov1901(saline),1
Biological,n-etsd (suspension for injection),1
Biological,nasopharyngeal swab,1
Biological,nasopharyngeal swabs,1
Biological,nasovax,1
Biological,nbp2001 adjuvanted with alum (rbd 30î¼g,1
Biological,nbp2001 adjuvanted with alum (rbd 30î¼g/dose),1
Biological,nbp2001 adjuvanted with alum (rbd 50î¼g,1
Biological,nbp2001 adjuvanted with alum (rbd 50î¼g/dose),1
Biological,nebulized platelet lysate,1
Biological,ngm621,1
Biological,no intervention,1
Biological,observational study: this registry data will provide more specific information about how people with blood cancer respond to covid-19 virus and,1
Biological,observational study: this registry data will provide more specific information about how people with blood cancer respond to covid-19 virus and/or a covid-19 vaccination.,1
Biological,octagam,1
Biological,one covid-19 vaccine candidate (tmv-083) administration - high dose,1
Biological,or a covid-19 vaccination.,1
Biological,oral polio vaccine / information,1
Biological,other clinical symptoms,1
Biological,other vaccine against sars-cov-2,1
Biological,otilimab,1
Biological,partially hla-matched sars-covsts,1
Biological,pcr/chest ct,1
Biological,peginterferon beta-1a,1
Biological,pembrolizumab,1
Biological,peripheral blood samples,1
Biological,placebo/aluminum adjuvant of inactivated sars-cov-2 vaccine,1
Biological,pneumococcal vaccine,1
Biological,ppv23,1
Biological,ppv23 for the 2nd dose,1
Biological,primepro,1
Biological,prolastin,1
Biological,psc-04,1
Biological,ptx-covid19-b,1
Biological,randomized booster,1
Biological,rapa-501-allo off-the-shelf therapy of covid-19,1
Biological,ravulizumab,1
Biological,recombinant human anti-sars-cov-2 monoclonal antibody(25mg,1
Biological,recombinant human anti-sars-cov-2 monoclonal antibody(25mg/kg;50mg/kg;100mg/kg),1
Biological,recombinant new coronavirus vaccine (cho cell) group,1
Biological,rectal swab,1
Biological,remdesivir,1
Biological,remestemcel-l,1
Biological,"reporting of anosmia, ageusia",1
Biological,"reporting of anosmia, ageusia/other clinical symptoms",1
Biological,respiratory tract sample,1
Biological,risankizumab,1
Biological,rph-104,1
Biological,sab-185,1
Biological,sam-lnp-s,1
Biological,sam-lnp-s-tce,1
Biological,sample,1
Biological,sarilumab,1
Biological,sars-cov-2 antibody based ivig therapy,1
Biological,sars-cov-2 antigen-specific cytotoxic t-lymphocytes,1
Biological,sars-cov-2 inactivated vaccine,1
Biological,sars-cov-2 mrna vaccine formulation 1,1
Biological,sars-cov-2 mrna vaccine formulation 2,1
Biological,sars-cov-2 mrna vaccine formulation 3,1
Biological,sars-cov-2 neutralizing antibody titer,1
Biological,sars-cov-2 recombinant protein vaccine formulation 1,1
Biological,sars-cov-2 recombinant protein vaccine formulation 2,1
Biological,sars-cov-2 recombinant protein vaccine formulation 3,1
Biological,sars-cov-2 rs/matrix-m1 adjuvant (crossover vaccination period),1
Biological,sars-cov-2 rs/matrix-m1 adjuvant (initial vaccination period),1
Biological,sars-cov-2 rs/matrix m1-adjuvant,1
Biological,sars-cov-2 specific t cells,1
Biological,sars-cov-2 vaccination,1
Biological,sars-cov-2 vaccine formulation 1 with adjuvant 1,1
Biological,sars-cov-2 vaccine formulation 1 with adjuvant 2,1
Biological,sars-cov-2 vaccine formulation 2 with adjuvant 1,1
Biological,sars-cov-2 vaccine formulation 2 with adjuvant 2,1
Biological,sars-cov-2 vaccine formulation 2 without adjuvant,1
Biological,"sars-cov-2 vaccine(vero cell), inactivated",1
Biological,sars-cov-2 virus vaccines,1
Biological,sbi-101,1
Biological,scb-2019,1
Biological,scb-2019 with as03 adjuvant,1
Biological,scb-2019 with cpg 1018 adjuvant,1
Biological,scb-2019 with cpg 1018 adjuvant/alum adjuvant,1
Biological,scta01,1
Biological,serological covid-19 vaccine immunogenicity,1
Biological,serological surveillance,1
Biological,"shingrix (zoster vaccine recombinant, adjuvanted)",1
Biological,soc/15mg/kg eb05 iv,1
Biological,specific anti-sars-cov-2 antibodies,1
Biological,specific antibody,1
Biological,specific antibody/cellular immune response after anti-sars-cov-2 vaccine administration,1
Biological,sputnik light,1
Biological,st266,1
Biological,standard care/placebo,1
Biological,stools,1
Biological,swab,1
Biological,t cell derived exosom,1
Biological,t memory cells,1
Biological,t memory cells/nk cells,1
Biological,tak-019,1
Biological,tak-919,1
Biological,therapeutic plasma exchange (tpe),1
Biological,"three doses of high-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14, 28",1
Biological,"three doses of high-dose recombinant sars-cov-2 vaccine (sf9 cell) at the schedule of day 0, 14, 28",1
Biological,"three doses of middle-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14, 28",1
Biological,thymic peptides,1
Biological,tigeraseâ®,1
Biological,tigeraseâ®/best available care,1
Biological,tocilizumab,1
Biological,trv027,1
Biological,two covid-19 vaccine candidate (tmv-083) administrations - high dose,1
Biological,two covid-19 vaccine candidate (tmv-083) administrations - low dose,1
Biological,two dose chadox1 ncov-19/covishield 0.25ml/0.5ml,1
Biological,two dose chadox1 ncov-19/covishield 0.5ml,1
Biological,two dose menacwy vaccine min. 4 weeks apart,1
Biological,"two doses of commercial scale inactivated sars-cov-2 vaccine at the schedule of day 0,14",1
Biological,"two doses of high-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14",1
Biological,"two doses of high-dose recombinant sars-cov-2 vaccine (sf9 cell) at the schedule of day 0, 28",1
Biological,"two doses of high dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",1
Biological,"two doses of middle-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14",1
Biological,"two doses of middle-dose recombinant sars-cov-2 vaccine (sf9 cell) at the schedule of day 0, 28",1
Biological,"two doses of pilot scale inactivated sars-cov-2 vaccine at the schedule of day 0,14",1
Biological,"two doses of pilot scale inactivated sars-cov-2 vaccine at the schedule of day 0,14 in elderly",1
Biological,utooth btc),1
Biological,v-sars,1
Biological,v590,1
Biological,v591,1
Biological,vaccinated with polio vaccine (ipv),1
Biological,vaccine therapy,1
Biological,vaccine: recombinant new coronavirus vaccine (cho cell) low-dose group,1
Biological,vaccine: recombinant new coronavirus vaccine (cho cells) high-dose group,1
Biological,vir-7831 (gen1),1
Biological,vir-7831 (gen2),1
Biological,vla2001,1
Biological,vxa-cov2-1,1
Biological,zofin,1
Combination Product,4plants,1
Combination Product,4plants/azythromycin,1
Combination Product,atazanavir/dexamethasone,1
Combination Product,autologous activated platelet-rich plasma,1
Combination Product,azd7442,1
Combination Product,cardiovascular,1
Combination Product,cardiovascular/respiratory systems monitoring,1
Combination Product,cospherunate/azythromycine,1
Combination Product,cospherunate/phytomedicine/azythromycien,1
Combination Product,device),1
Combination Product,dexamethasone,1
Combination Product,favipiravir,1
Combination Product,favipiravir/hydroxychloroquine,1
Combination Product,hydroxychloroquine/azithromycin/ tocilizumab,1
Combination Product,immunofree tablets,1
Combination Product,immunofree tablets/reginmune capsule,1
Combination Product,inopulse,1
Combination Product,insulin film,1
Combination Product,iota carrageenan nasal spray,1
Combination Product,iota carrageenan nasal spray/ivermectin oral drops (used as buccal drops),1
Combination Product,ivermectin,1
Combination Product,"jinhua qinggan (jhqg) granules, traditional chinese medicine",1
Combination Product,mefloquine,1
Combination Product,mefloquine/azithromycin/ tocilizumab,1
Combination Product,mesenchymal stem cells,1
Combination Product,monoclonal antibody,1
Combination Product,mw33 injection,1
Combination Product,na-831/atazanavir,1
Combination Product,na-831/dexamethasone,1
Combination Product,nutrition consult,1
Combination Product,nutrition consult/protein supplementation,1
Combination Product,observational,1
Combination Product,oxygen,1
Combination Product,phytomedicine,1
Combination Product,polio vaccine,1
Combination Product,polio vaccine/na-831,1
Combination Product,protein supplementation,1
Combination Product,quinquina-stevia,1
Combination Product,quinquina-stevia/azythromycin,1
Combination Product,reginmune,1
Combination Product,respiratory rehabilitation,1
Combination Product,respiratory systems monitoring,1
Combination Product,standard therapy for covid-19 patient,1
Combination Product,systemic,1
Device,accuchek inform ii platform,1
Device,actigraphy,1
Device,adam sensor,1
Device,aerosol box,1
Device,alexa amazon,1
Device,anne one,1
Device,apple watch,1
Device,assessment),1
Device,audio-visual triage system (avt),1
Device,auricular percutaneous neurostimulation,1
Device,auscul-x,1
Device,bidirectional oxygenation mouthpiece,1
Device,biosensor,1
Device,biovitals,1
Device,breath biopsy face masks with removable filters,1
Device,breath biopsy face masks with removable filters/fitted pva strip,1
Device,butterfly iq,1
Device,bva-100,1
Device,c3,1
Device,c3/ holter monitor,1
Device,canswab,1
Device,cardiac,1
Device,cardiac/electrodermal recordings,1
Device,carragelose,1
Device,cbc-diff monocyte volume width distribution,1
Device,centricyte 1000,1
Device,cerebral compliance,1
Device,cerebral compliance/hemodynamics monitoring,1
Device,clinical decision support system based on non-invasive multimodal monitoring,1
Device,cliniporator,1
Device,cliniporatorâ®,1
Device,cliniporatorâ®/epsgun,1
Device,closed-loop control of oxygen supplementation by o2matic,1
Device,connected devices measurements,1
Device,continuous blind glucose measurement device (free style pro),1
Device,continuous glucose monitor (cgm),1
Device,continuous positive airway pressure,1
Device,continuous positive airway pressure (cpap) treatment,1
Device,continuous vital sign monitoring - isansys patient status engine,1
Device,contrast-enhanced cmr,1
Device,control,1
Device,control swab,1
Device,conventional n95 respirator,1
Device,conventional oxygen therapy,1
Device,conventional therapy first,1
Device,cordio app,1
Device,core warming,1
Device,coronacheck device,1
Device,cov-scan rapid covid-19 antigen test,1
Device,covid-19 barrier box,1
Device,covsurf drug delivery system,1
Device,covx,1
Device,cri management,1
Device,current health,1
Device,current ipac-uhn ppe,1
Device,device used to record voice for screening,1
Device,dexcom,1
Device,digital oximeter monitoring,1
Device,digivis visual acuity app,1
Device,doctor spot,1
Device,earsats pulse oximeter probe,1
Device,ecco2r,1
Device,ecg,1
Device,echocardiography,1
Device,electric pad for human external pain therapy,1
Device,electrical impedance tomography,1
Device,electrical stimulation,1
Device,electrical stimulation - sham,1
Device,electrodermal recordings,1
Device,elmo project at covid-19: proof of concept,1
Device,elmo project at covid-19: proof of concept/usability,1
Device,endoscopy,1
Device,epsgun,1
Device,extracorporeal membrane oxygenation,1
Device,face-mask niv,1
Device,face mask,1
Device,facial mask,1
Device,familychildcare (provisional name of app),1
Device,fast dissolving film,1
Device,fecal,1
Device,ffp2,1
Device,filtration test,1
Device,fitted pva strip,1
Device,flow controlled ventilation (evone-ventilator),1
Device,freestyle libre 14 day cgm system,1
Device,go2 peep mouthpiece,1
Device,hcfwo,1
Device,helmet niv,1
Device,helmet non-invasive ventilation,1
Device,hemodynamics monitoring,1
Device,high-flow nasal cannula treatment,1
Device,high flow nasal therapy,1
Device,holter monitor,1
Device,home pulse oximetry monitoring,1
Device,hospital telemedicine management system,1
Device,hydrogen oxygen generator with nebulizer,1
Device,igg,1
Device,igm antibodytest,1
Device,igm/igg rapid test,1
Device,innova lateral flow device,1
Device,intraosseous,1
Device,intravenous,1
Device,invasive mechanical ventilation using the unisabana-herons ventilator during 24 hours,1
Device,kelea water,1
Device,laryngoscope,1
Device,lifesignals biosensor 1ax*,1
Device,limbix spark,1
Device,lung ultrasonography,1
Device,lung ultrasound,1
Device,lus fourteen area,1
Device,lus twelve area,1
Device,magec spine rod,1
Device,makair,1
Device,"masimo, lidco",1
Device,mcgrath videolaryngoscope,1
Device,medical mask,1
Device,meditation,1
Device,mejoracare,1
Device,mfs,1
Device,miniprobe alveoflex,1
Device,mls laser,1
Device,modified ipac-uhn ppe,1
Device,mouthrinse with bãªta-cyclodextrin,1
Device,mouthrinse with bãªta-cyclodextrin/citrox,1
Device,mouthrinse without bãªta-cyclodextrin,1
Device,mouthrinse without bãªta-cyclodextrin/citrox,1
Device,multifrequency bioimpedance spectroscopy,1
Device,musclesound ultrasound,1
Device,n95 respirator,1
Device,nasal high flow,1
Device,nebulized administration of rlf-100,1
Device,nebulized administration of rlf-100/placebo,1
Device,neuromuscular,1
Device,neuromuscular electrical stimulation,1
Device,no personal protective equipment (ppe),1
Device,non-contact mce system,1
Device,non-invasive ventilatory support,1
Device,noninvasive ventilation,1
Device,noninvasive ventilation treatment,1
Device,nowdx covid-19 test,1
Device,observational measurement of biometric data. no change to health care provided.,1
Device,observational study - no intervention,1
Device,olfactory device,1
Device,online self-help intervention,1
Device,oxygen hood,1
Device,oxyhydrogen,1
Device,patient status engine,1
Device,pbmt,1
Device,pbmt/smf,1
Device,pep flute,1
Device,percutaneous coronary revascularization for stemi,1
Device,performance evaluation study of realdetect rt-pcr kit for covid-19 detection,1
Device,performing of lung ultrasound,1
Device,personal protective equipment,1
Device,personal protective equipment (ppe),1
Device,philips lumify ultrasound system,1
Device,"platelet function analyzer scp1, sienco, usa",1
Device,power breathe,1
Device,prototype,1
Device,pulse oximeter,1
Device,q-nrg metobolic cart device,1
Device,radius ppg tetherless pulse oximetry (masimo),1
Device,rapid test,1
Device,rd-x19,1
Device,rehabilitation of cognitive function after remission of the symptoms of covid-19,1
Device,respiratory monitor,1
Device,ria-device (remote investigation,1
Device,ria-device (remote investigation/assessment),1
Device,robotic assisted early mobilization,1
Device,robotic therapy,1
Device,saliva assay,1
Device,saliva test kit,1
Device,savr,1
Device,scd,1
Device,seraph,1
Device,sledd with a l-mod,1
Device,sodium,1
Device,sonclot coagulation,1
Device,"sonclot coagulation/platelet function analyzer scp1, sienco, usa",1
Device,soterix tavns model 0125-lte stimulator - active-active group,1
Device,soterix tavns model 0125-lte stimulator - sham-active group,1
Device,spartan covid-19 system,1
Device,standard care,1
Device,tape-software,1
Device,tavr,1
Device,tavr/savr,1
Device,tcc-covid mhealth,1
Device,telehealth,1
Device,tensile strength,1
Device,test group: experimental - uvc therapy applied,1
Device,the use of the mentalplusâ® digital game for assessment,1
Device,the use of the mentalplusâ® digital game for assessment/rehabilitation of cognitive function after remission of the symptoms of covid-19,1
Device,tof protocol,1
Device,transcranial direct current stimulation,1
Device,transcutaneous auricular vagus nerve stimulation,1
Device,transparent sheet,1
Device,transpulmonary thermodilution,1
Device,usability,1
Device,"use of the pinpointiq solution (physiq, inc.)",1
Device,usual monitoring,1
Device,uv light treatment,1
Device,uvc irradiation,1
Device,vascular occlusion test,1
Device,vesta respirator,1
Device,vibrolung,1
Device,vielight rx plus,1
Device,virtual reality,1
Device,virtual reality therapy first,1
Device,viruxal oral,1
Device,viruxal oral/nasal spray,1
Device,volatile organic compounds analysis (e-noses),1
Device,volatile organic compounds analysis (mass spectrometry),1
Device,volatile organic compounds analysis in sweat (mass spectrometry),1
Device,vv-ecmo / cytokine adsorption,1
Device,ward css,1
Device,water without an elevated level of kelea,1
Device,wearable medical device (empatica e4),1
Device,web-application,1
Device,web application users,1
Device,withings scanwatch,1
Diagnostic Test,": igg, ig m serologies in the amniotoc fluid, the blood cord",1
Diagnostic Test,[68ga]ga-dota-(rgd)2 pet,1
Diagnostic Test,[68ga]ga-dota-(rgd)2 pet/ct,1
Diagnostic Test,24 hour holter ecg,1
Diagnostic Test,25 post icu-patients,1
Diagnostic Test,40-steps-test,1
Diagnostic Test,4c mortality score,1
Diagnostic Test,6 minute walk test,1
Diagnostic Test,a questionnaire,1
Diagnostic Test,a questionnaire/scales,1
Diagnostic Test,aaz covid-19 rapid test,1
Diagnostic Test,abpm,1
Diagnostic Test,adaptation at work score (psas),1
Diagnostic Test,ai model,1
Diagnostic Test,amh sampling,1
Diagnostic Test,angiogenic biomarkers,1
Diagnostic Test,anti-covid test,1
Diagnostic Test,anti-sars-cov2 serological controls,1
Diagnostic Test,anti-sars-cov2 serological controls/serum neutralization,1
Diagnostic Test,anti covid19 igg antibodies,1
Diagnostic Test,"antibody tests,",1
Diagnostic Test,arterial blood gas,1
Diagnostic Test,"assessing antibody responses, neutralizing capacity",1
Diagnostic Test,"assessing antibody responses, neutralizing capacity/memory b-cell function",1
Diagnostic Test,assessment of cardiovascular diseases,1
Diagnostic Test,assessment of cardiovascular diseases/cardiovascular risk factors,1
Diagnostic Test,assessment of ventilator-associated pneumonia criteria,1
Diagnostic Test,asynchronies detection,1
Diagnostic Test,axillary sweat sample,1
Diagnostic Test,baseline spirometry,1
Diagnostic Test,bd lyotubes,1
Diagnostic Test,"biomarker (tropt, myoglobin, ck, ck-mb, ldh, d-dimer, crp, pct)",1
Diagnostic Test,biomarkers expression,1
Diagnostic Test,biomarkers of inflammation,1
Diagnostic Test,biozek covid-19 antigen rapid test,1
Diagnostic Test,blood group determination,1
Diagnostic Test,blood sampling (venesection),1
Diagnostic Test,blood test for sars-cov2 serology,1
Diagnostic Test,bloodwork,1
Diagnostic Test,brain mri,1
Diagnostic Test,breath biopsy,1
Diagnostic Test,breath test/cheek swab,1
Diagnostic Test,bronchoalveolar lavage,1
Diagnostic Test,butterfly,1
Diagnostic Test,c-reactive protein,1
Diagnostic Test,cambridge validated viral detection,1
Diagnostic Test,capillary collection,1
Diagnostic Test,capillary collection/testing,1
Diagnostic Test,capnography,1
Diagnostic Test,cardiac ct,1
Diagnostic Test,cardiac mri,1
Diagnostic Test,cardiopulmonary exercise test,1
Diagnostic Test,cardiovascular magnetic resonance imaging,1
Diagnostic Test,cardiovascular risk factors,1
Diagnostic Test,carotid artery reactivity testing,1
Diagnostic Test,cellular immunity,1
Diagnostic Test,cellular response,1
Diagnostic Test,cheek swab,1
Diagnostic Test,chest computed tomography,1
Diagnostic Test,chest ct scan / baseline spirometry,1
Diagnostic Test,chest mri,1
Diagnostic Test,chest x-ray,1
Diagnostic Test,chitotriosidase activity,1
Diagnostic Test,clinical features,1
Diagnostic Test,clinical features/laboratory values,1
Diagnostic Test,clinico-biological parameters in routine care,1
Diagnostic Test,clungene rapid test cassette,1
Diagnostic Test,collection of breath sample,1
Diagnostic Test,collection of swabs,1
Diagnostic Test,comet assay,1
Diagnostic Test,complement dosage,1
Diagnostic Test,conjunctival swab/nasopharyngeal swab,1
Diagnostic Test,copan swabbing,1
Diagnostic Test,copan swabbing/blood sample collection,1
Diagnostic Test,covid-19 antibody testing,1
Diagnostic Test,"covid-19 antigen/antibody rapid testing, mobile device image capture/telemedicine support",1
Diagnostic Test,"covid-19 antigen/antibody tests,/influenza rapid test",1
Diagnostic Test,covid-19 diagnostic test,1
Diagnostic Test,covid-19 nasal,1
Diagnostic Test,covid-19 nasal/pharyngeal swab,1
Diagnostic Test,"covid-19 pcr , igm",1
Diagnostic Test,covid-19 pcr swab,1
Diagnostic Test,covid-19 positive,1
Diagnostic Test,covid-19 presto test,1
Diagnostic Test,covid-19 serology igg,1
Diagnostic Test,covid-19 swab,1
Diagnostic Test,covid-19 test,1
Diagnostic Test,covid-19 testing,1
Diagnostic Test,covid-antibody test,1
Diagnostic Test,covid 19 diagnostic test,1
Diagnostic Test,covid 19 serology,1
Diagnostic Test,covid19 rt-pcr,1
Diagnostic Test,covidseq test,1
Diagnostic Test,ct scan,1
Diagnostic Test,ctus examination,1
Diagnostic Test,cube rapid test,1
Diagnostic Test,cystatin c,1
Diagnostic Test,cytokines,1
Diagnostic Test,cytokines measurement,1
Diagnostic Test,data,1
Diagnostic Test,data collection,1
Diagnostic Test,data collection/rhinopharyngeal swab,1
Diagnostic Test,ddpcr,1
Diagnostic Test,"depression,",1
Diagnostic Test,determination of sars-cov2 presence in cns,1
Diagnostic Test,"diagnosis of sars-cov2 by rt-pcr/: igg, ig m serologies in the amniotoc fluid, the blood cord/the placenta",1
Diagnostic Test,diagnostic,1
Diagnostic Test,diagnostic examination for venous thromboembolism,1
Diagnostic Test,diagnostic test,1
Diagnostic Test,diagnostic test covid-19,1
Diagnostic Test,diagnostic test for detection of sars-cov-2,1
Diagnostic Test,diagnostic test for sars-cov2 for patients,1
Diagnostic Test,diagnostic test for sars-cov2 for patients/health staff,1
Diagnostic Test,diagnostic tests for covid-19 infection,1
Diagnostic Test,diffusing capacity of carbon monoxide,1
Diagnostic Test,direct antigen tests for covid-19,1
Diagnostic Test,direct antigen tests for sars-cov-2,1
Diagnostic Test,dry blood spot collection (euroimmun),1
Diagnostic Test,duplex sonography,1
Diagnostic Test,duplex ultrasound/computed tomography angiography,1
Diagnostic Test,easycov poc,1
Diagnostic Test,echo-doppler,1
Diagnostic Test,echocardiogram,1
Diagnostic Test,eeg,1
Diagnostic Test,ejaculated semen sample,1
Diagnostic Test,electro impedance tomography,1
Diagnostic Test,electrocardiogram (ecg),1
Diagnostic Test,"electrocardiogram, telemetry, echocardiogram, laboratory values",1
Diagnostic Test,"electrocardiogram, transthoracic echocardiography",1
Diagnostic Test,"electrocardiogram, transthoracic echocardiography/clinico-biological parameters in routine care",1
Diagnostic Test,"electrocardiography ,tomographic imaging",1
Diagnostic Test,elisa/rapid test to detect antibodies against covid-19,1
Diagnostic Test,elispot,1
Diagnostic Test,endothelial damage,1
Diagnostic Test,endothelial damage/angiogenic biomarkers,1
Diagnostic Test,ent exam,1
Diagnostic Test,ep,1
Diagnostic Test,euroimmun assay,1
Diagnostic Test,evaluation,1
Diagnostic Test,"evaluation of clinical, instrumental",1
Diagnostic Test,"evaluation of clinical, instrumental/laboratory diagnostics tests",1
Diagnostic Test,even birth year intervention groups,1
Diagnostic Test,examinations for the research:,1
Diagnostic Test,exercise test ecg,1
Diagnostic Test,face mask sampling,1
Diagnostic Test,fibreoptic endoscopic evaluation of swallowing (fees),1
Diagnostic Test,filmarray pneumonia,1
Diagnostic Test,fingerstick,1
Diagnostic Test,fingertip tests for poc assays,1
Diagnostic Test,fmd,1
Diagnostic Test,functional mri,1
Diagnostic Test,fungal rhinosinusitis,1
Diagnostic Test,gas exchange measurement,1
Diagnostic Test,global longitudinal strain,1
Diagnostic Test,glycomic analysis,1
Diagnostic Test,health-related quality of life,1
Diagnostic Test,health staff,1
Diagnostic Test,home sleep apnea testing,1
Diagnostic Test,home sleep apnea testing/in-hospital polysomnography,1
Diagnostic Test,home spirometry,1
Diagnostic Test,"hormone levels (testosterone, fsh, lh, prolactin)",1
Diagnostic Test,hospital anxiety depression scale,1
Diagnostic Test,humoral,1
Diagnostic Test,humoral/cellular immunity,1
Diagnostic Test,id now vs. accula,1
Diagnostic Test,igg antibodies assay,1
Diagnostic Test,igg neutralising antibody titers to s1,1
Diagnostic Test,igg neutralising antibody titers to s1/s2 proteins of sars-cov-2 virus,1
Diagnostic Test,igg sars cov 2 antibodies,1
Diagnostic Test,igg sars cov2,1
Diagnostic Test,"igg, aaz, boulogne-billancourt, france)",1
Diagnostic Test,igm test,1
Diagnostic Test,igm/igg antibodies assay,1
Diagnostic Test,imaging,1
Diagnostic Test,imaging by thoracic scanner,1
Diagnostic Test,"imaging, blood tests",1
Diagnostic Test,immune response study,1
Diagnostic Test,immunfluorescence,1
Diagnostic Test,indirect calorimetry,1
Diagnostic Test,influenza rapid test,1
Diagnostic Test,interleukin,1
Diagnostic Test,ip-10,1
Diagnostic Test,kir phenotype evaluation,1
Diagnostic Test,lab workup (on admission,1
Diagnostic Test,lab workup (on admission/regularly during follow up).,1
Diagnostic Test,laboratory,1
Diagnostic Test,laboratory analyses,1
Diagnostic Test,laboratory diagnostics tests,1
Diagnostic Test,laboratory samples,1
Diagnostic Test,laboratory values,1
Diagnostic Test,lamp,1
Diagnostic Test,liver function tests,1
Diagnostic Test,lung biopsy,1
Diagnostic Test,lung function test,1
Diagnostic Test,lung function tests,1
Diagnostic Test,lung impedance,1
Diagnostic Test,lung ultrasound use in patients hospitalized with covid,1
Diagnostic Test,machine learning classification of parenchymal lung change cause,1
Diagnostic Test,machine learning classification of recurrence,1
Diagnostic Test,machine learning classification of recurrence/non-recurrence,1
Diagnostic Test,machine learning model,1
Diagnostic Test,magnetic resonance imaging,1
Diagnostic Test,mcc ims,1
Diagnostic Test,memory b-cell function,1
Diagnostic Test,metabolomic,1
Diagnostic Test,microcirculation recording,1
Diagnostic Test,"mri (heart, brain, lungs, liver)",1
Diagnostic Test,mrna in urine test,1
Diagnostic Test,multicapillary column coupled ion mobility spectrometry,1
Diagnostic Test,multitest 6 color tbnk,1
Diagnostic Test,multitest 6 color tbnk/bd lyotubes,1
Diagnostic Test,nasopharyngeal,1
Diagnostic Test,nasopharyngeal (np) swab,1
Diagnostic Test,nasopharyngeal samples,1
Diagnostic Test,nasopharyngeal swabs,1
Diagnostic Test,nasopharyngeal/throat/oropharyngeal swabs analyses by rt-pcr/ddpcr,1
Diagnostic Test,netosis markers,1
Diagnostic Test,neural network diagnosis algorithm,1
Diagnostic Test,neuroimaging findings in patients with covid-19,1
Diagnostic Test,neurology test,1
Diagnostic Test,neuropsychological assessment,1
Diagnostic Test,ng test,1
Diagnostic Test,no intervention,1
Diagnostic Test,no intervention planned due to the observational study design only a diagnostic testing,1
Diagnostic Test,non-recurrence,1
Diagnostic Test,"nose swabs, bronchoalveolar lavage ,urine)",1
Diagnostic Test,not required,1
Diagnostic Test,nps test,1
Diagnostic Test,"obtainment of nasopharyngeal, oropharyngeal, buccal, nasal",1
Diagnostic Test,"obtainment of nasopharyngeal, oropharyngeal, buccal, nasal/saliva samples",1
Diagnostic Test,odd,1
Diagnostic Test,odd/even birth year intervention groups,1
Diagnostic Test,olfactometry,1
Diagnostic Test,on-site testing (lumiradx),1
Diagnostic Test,optical coherence tomography (oct),1
Diagnostic Test,optical coherence tomography angiography,1
Diagnostic Test,oropharyngeal swabs analyses by rt-pcr,1
Diagnostic Test,oxidative stress elisa kit,1
Diagnostic Test,paraclinical test,1
Diagnostic Test,passive microwave radiometry,1
Diagnostic Test,pcr test,1
Diagnostic Test,pcr value,1
Diagnostic Test,pct,1
Diagnostic Test,performance of the test antigenic,1
Diagnostic Test,performance of the test antigenic/test rt-pcr,1
Diagnostic Test,performing ai algorithms on images,1
Diagnostic Test,peripheral lymphocytes subsets,1
Diagnostic Test,peripheral venous ultrasound,1
Diagnostic Test,pet-ct of 18f-fdg,1
Diagnostic Test,pharyngeal swab,1
Diagnostic Test,phlebotomy,1
Diagnostic Test,physical examination,1
Diagnostic Test,pilot a rapid sars-cov-2 testing strategy,1
Diagnostic Test,plasma igg levels,1
Diagnostic Test,"platelet count, platelet, mean platelet volume",1
Diagnostic Test,"platelet count, platelet, mean platelet volume/platelet distribution width in covid-19",1
Diagnostic Test,platelet distribution width in covid-19,1
Diagnostic Test,point-of-care rapid anti-sars-cov-2 antibody test (orient gene biotech),1
Diagnostic Test,point-of-care rapid anti-sars-cov-2 antibody test (orient gene biotech)/dry blood spot collection (euroimmun),1
Diagnostic Test,point-of-care test for sars-cov-2,1
Diagnostic Test,"point of care ultrasound including echocardiography, lung ultrasound, vascular ultrasound",1
Diagnostic Test,polysomnography,1
Diagnostic Test,pool lamp,1
Diagnostic Test,pool rt-pcr,1
Diagnostic Test,positive for sars-cov-2 infection,1
Diagnostic Test,post-traumatic stress screening,1
Diagnostic Test,presence of specific anti-sars-cov-2 antibodies,1
Diagnostic Test,prognostic score,1
Diagnostic Test,psychological stress,1
Diagnostic Test,psychological stress/adaptation at work score (psas),1
Diagnostic Test,public health england gold standard,1
Diagnostic Test,pulmonary anomalies 4 months after documented covid-19 pneumonia,1
Diagnostic Test,pulmonary function testing,1
Diagnostic Test,pulse oximeter,1
Diagnostic Test,pulse oximetry,1
Diagnostic Test,pwv,1
Diagnostic Test,qrt-pcr,1
Diagnostic Test,qrt-pcr/serology,1
Diagnostic Test,qualitative,1
Diagnostic Test,qualitative assessments of mental health,1
Diagnostic Test,qualitative/quantitative virus pcr of respiratory secretions in patients with high aerosol concentrations,1
Diagnostic Test,quantitative,1
Diagnostic Test,quantitative analysis of anti-sars-cov-2-antibodies,1
Diagnostic Test,quantitative analysis of sars-cov-2 antibodies,1
Diagnostic Test,quantitative igg test,1
Diagnostic Test,quantitative virus pcr of respiratory secretions in patients with high aerosol concentrations,1
Diagnostic Test,quantitative/qualitative assessments of mental health,1
Diagnostic Test,quantra system,1
Diagnostic Test,quasistatic pressure-volume curve,1
Diagnostic Test,questionnaires family,1
Diagnostic Test,questionnaires patient,1
Diagnostic Test,radiological,1
Diagnostic Test,rapid antigen test,1
Diagnostic Test,rapid antigen test for sars cov2,1
Diagnostic Test,rapid salivary test,1
Diagnostic Test,rarefaction,1
Diagnostic Test,recombinase,1
Diagnostic Test,regularly during follow up).,1
Diagnostic Test,repeat sars-cov-2 igg antibodies at 45-65 days,1
Diagnostic Test,resp-aer-meter,1
Diagnostic Test,respiratory mechanics measurement,1
Diagnostic Test,respiratory monitoring,1
Diagnostic Test,respiratory muscles ultrasound,1
Diagnostic Test,respiratory swabs,1
Diagnostic Test,"respiratory symptoms, symptoms of anxiety",1
Diagnostic Test,"respiratory symptoms, symptoms of anxiety/depression,/post-traumatic stress screening",1
Diagnostic Test,resting 12 lead ecg,1
Diagnostic Test,reverse transcription polymerase chain reaction,1
Diagnostic Test,rhinopharyngeal,1
Diagnostic Test,rt-qpcr test,1
Diagnostic Test,s2 proteins of sars-cov-2 virus,1
Diagnostic Test,saint george respiratory questionnaire,1
Diagnostic Test,saliva collected via salivette cortisol,1
Diagnostic Test,saliva/nps test,1
Diagnostic Test,salivary,1
Diagnostic Test,samba ii,1
Diagnostic Test,sample collection/performance evaluation (a),1
Diagnostic Test,sample collection/performance evaluation (b),1
Diagnostic Test,sampling of sars-cov-2 rna from nasopharyngeal swab specimen,1
Diagnostic Test,sampling of sars-cov-2 rna from nasopharyngeal swab specimen/saliva collected via salivette cortisol,1
Diagnostic Test,sars-cov-2-test,1
Diagnostic Test,sars-cov-2 ab,1
Diagnostic Test,sars-cov-2 antibody analysis,1
Diagnostic Test,sars-cov-2 antibody immunoassays,1
Diagnostic Test,sars-cov-2 antibody test,1
Diagnostic Test,sars-cov-2 antibody testing,1
Diagnostic Test,sars-cov-2 ig g levels,1
Diagnostic Test,sars-cov-2 igg,1
Diagnostic Test,sars-cov-2 pcr/serology tests,1
Diagnostic Test,sars-cov-2 rapid diagnostic test (covid-prestoâ® igm,1
Diagnostic Test,"sars-cov-2 rapid diagnostic test (covid-prestoâ® igm/igg, aaz, boulogne-billancourt, france)",1
Diagnostic Test,"sars-cov-2 research in nasopharyngeal swab, sperm",1
Diagnostic Test,"sars-cov-2 research in nasopharyngeal swab, sperm/serologics",1
Diagnostic Test,sars-cov-2 rt-pcr assay for detection of covid-19 infection,1
Diagnostic Test,sars-cov-2 s1,1
Diagnostic Test,sars-cov-2 s1/s2 igg,1
Diagnostic Test,sars-cov-2 serological assessment (igg),1
Diagnostic Test,sars-cov-2 serology,1
Diagnostic Test,sars-cov-2 testing on the eppendorf thermal cycler pcr system using self-collected saliva as the specimen,1
Diagnostic Test,sars-cov2 testing,1
Diagnostic Test,scales,1
Diagnostic Test,scanning chest x-rays/performing ai algorithms on images,1
Diagnostic Test,self-administered questionnaire,1
Diagnostic Test,semen analysis,1
Diagnostic Test,semen qualitative analysis,1
Diagnostic Test,senior fitness test,1
Diagnostic Test,sequence of testing.,1
Diagnostic Test,serologic assays for antibodies to sars-cov-2,1
Diagnostic Test,serologic immunoassays to sars-cov-2 antibodies,1
Diagnostic Test,serologic test,1
Diagnostic Test,serological assay for sars-cov-2,1
Diagnostic Test,serological testing for covid-19 infection,1
Diagnostic Test,serological tests for sars cov-2,1
Diagnostic Test,serology test for covid-19,1
Diagnostic Test,serology tests,1
Diagnostic Test,serology to determine sars-cov-2 infection,1
Diagnostic Test,serum neutralization,1
Diagnostic Test,serum ngal,1
Diagnostic Test,serum ngal/cystatin c,1
Diagnostic Test,simple chest tomography,1
Diagnostic Test,single passive leg movement,1
Diagnostic Test,sit to stand test,1
Diagnostic Test,soluble urokinase plasminogen activator receptor,1
Diagnostic Test,sonoclot,1
Diagnostic Test,spartan covid-19 platform,1
Diagnostic Test,spartan covid-19 test,1
Diagnostic Test,spartan covid-19 v2 system,1
Diagnostic Test,specimen collection,1
Diagnostic Test,sperm test,1
Diagnostic Test,"spirometry, thoracic ct, cpet, 6 minute walking test, sf-36 questionnaire",1
Diagnostic Test,"standard q covid-19 ag - test, produced by sd biosensor inc.",1
Diagnostic Test,stc-19,1
Diagnostic Test,stimulation test with arginine infusion in order to verify the possible existence of damage to the beta cell function induced by covid-19 infection,1
Diagnostic Test,stool collection,1
Diagnostic Test,study of immune-mediated mechanisms in patients tested positive for sars-cov-2,1
Diagnostic Test,"supar, c-reactive protein, ferritin, d-dimer, procalcitonin, interleukin-6, lactate dehydrogenase",1
Diagnostic Test,survey,1
Diagnostic Test,susceptibility to infection,1
Diagnostic Test,suspected of covid-19 infection,1
Diagnostic Test,swabbing of conjunctiva,1
Diagnostic Test,swallowing evaluation with the eat-10,1
Diagnostic Test,swallowing evaluation with the eat-10/the volume-viscosity swallowing test (v-vst),1
Diagnostic Test,tears swab,1
Diagnostic Test,telehealth,1
Diagnostic Test,tem-tpa,1
Diagnostic Test,test,1
Diagnostic Test,test rt-pcr,1
Diagnostic Test,testing for sars-cov-2,1
Diagnostic Test,testing sensitivity for sars-cov-2 virus in symptomatic individuals,1
Diagnostic Test,testnpass,1
Diagnostic Test,"the demographic, clinical, laboratory,",1
Diagnostic Test,"the demographic, clinical, laboratory,/instrumental data",1
Diagnostic Test,the placenta,1
Diagnostic Test,thoracic ct,1
Diagnostic Test,thorax ct,1
Diagnostic Test,thoraxic computed tomography,1
Diagnostic Test,throat,1
Diagnostic Test,throat swab,1
Diagnostic Test,throat swab sample for measuring current infection with sars-cov-2,1
Diagnostic Test,titanium blood test,1
Diagnostic Test,tlrs activation measurement,1
Diagnostic Test,tomography angiography,1
Diagnostic Test,transpulmonary pressure measurements,1
Diagnostic Test,tuberculin,1
Diagnostic Test,ultrasonography,1
Diagnostic Test,"urinary ngal, timp-2, igfbp7, il-6, viral load",1
Diagnostic Test,"urinary ngal, timp-2, igfbp7, il-6, viral load/metabolomic",1
Diagnostic Test,venous blood was collected for biochemistry testing,1
Diagnostic Test,venous blood was collected for biochemistry testing.,1
Diagnostic Test,venous draw,1
Diagnostic Test,venous draw/testing,1
Diagnostic Test,videofluoroscopic swallowing study (vfss),1
Diagnostic Test,videofluoroscopy,1
Diagnostic Test,visual analogue scale,1
Diagnostic Test,vitros anti-sars-cov-2 igg test,1
Diagnostic Test,volume rapid test,1
Diagnostic Test,weck-cel swab collection,1
Diagnostic Test,whole exome sequencing,1
Diagnostic Test,x-ray,1
Dietary Supplement,,1
Dietary Supplement,5-ala-phosphate,1
Dietary Supplement,5-ala-phosphate / sfc (5-ala / sfc),1
Dietary Supplement,600mg) oral suspension,1
Dietary Supplement,abbc1 immunoessential,1
Dietary Supplement,alanine,1
Dietary Supplement,antioxidants,1
Dietary Supplement,arbox,1
Dietary Supplement,artemesia annua,1
Dietary Supplement,ascorbic acid/zinc gluconate,1
Dietary Supplement,ayurveda,1
Dietary Supplement,ayurvedic kadha,1
Dietary Supplement,bovine plasma-derived immunoglobulin concentrate,1
Dietary Supplement,broad-spectrum cbd oil,1
Dietary Supplement,bromelain,1
Dietary Supplement,cbd isolate,1
Dietary Supplement,cod liver oil,1
Dietary Supplement,control,1
Dietary Supplement,cretan iama,1
Dietary Supplement,diet,1
Dietary Supplement,diet/sun exposure,1
Dietary Supplement,dietary supplement,1
Dietary Supplement,dietary supplementation in patients with covid disease admitted to hospital,1
Dietary Supplement,full spectrum cbd oil,1
Dietary Supplement,honey,1
Dietary Supplement,immunoformulation,1
Dietary Supplement,inflammation (i),1
Dietary Supplement,inflammation (ii),1
Dietary Supplement,inflammation (iii),1
Dietary Supplement,investigational product - viracide,1
Dietary Supplement,ketogenic diet with phytoextracts,1
Dietary Supplement,l-citrulline,1
Dietary Supplement,l. reuteri dsm 17938,1
Dietary Supplement,l. reuteri dsm 17938 / vitamin d,1
Dietary Supplement,lactobacillus,1
Dietary Supplement,lactobaciltus rhamnosus gg,1
Dietary Supplement,"lactoferrin, green tea extract",1
Dietary Supplement,licorice extract,1
Dietary Supplement,m capsules 148 mg,1
Dietary Supplement,maf capsules 148 mg,1
Dietary Supplement,magnesium stearate),1
Dietary Supplement,manremyc,1
Dietary Supplement,melatonin,1
Dietary Supplement,micronized,1
Dietary Supplement,"micronized/ultra-micronized palmitoylethanolamide (mpea/umpea, 300mg / 600mg) oral suspension",1
Dietary Supplement,molecular hydrogen,1
Dietary Supplement,multivitamin with 11mg of zinc,1
Dietary Supplement,n-acetyl glucosamine (nag),1
Dietary Supplement,n-acetylcysteine,1
Dietary Supplement,nad,1
Dietary Supplement,nad/,1
Dietary Supplement,nicotinamide,1
Dietary Supplement,nicotinamide riboside,1
Dietary Supplement,nigella sativa,1
Dietary Supplement,nricm101,1
Dietary Supplement,omnibiotic aad,1
Dietary Supplement,oxaloacetate medical food,1
Dietary Supplement,oxaloacetate medical food/dietary supplement,1
Dietary Supplement,placebo (potato starch/magnesium stearate),1
Dietary Supplement,placebo / vitamin d,1
Dietary Supplement,preservision areds formulation soft gels,1
Dietary Supplement,preservision areds formulation soft gels/tablets,1
Dietary Supplement,probiotics,1
Dietary Supplement,probiotics (2 strains 10x10^9 ufc),1
Dietary Supplement,proper diet,1
Dietary Supplement,quadramune(tm),1
Dietary Supplement,quercetin phytosome,1
Dietary Supplement,resveratrol,1
Dietary Supplement,sfc (5-ala,1
Dietary Supplement,sfc),1
Dietary Supplement,sun exposure,1
Dietary Supplement,tablets,1
Dietary Supplement,traditional chinese medicine,1
Dietary Supplement,ultra-micronized palmitoylethanolamide (mpea,1
Dietary Supplement,"umpea, 300mg",1
Dietary Supplement,vitamin b,1
Dietary Supplement,vitamin k2 in the form of menaquinone-7 (mk-7),1
Dietary Supplement,vitamine d3 supplementation,1
Dietary Supplement,vitamins,1
Dietary Supplement,viusid/asbrip,1
Dietary Supplement,zinc acetate,1
Dietary Supplement,zinc citrate,1
Dietary Supplement,zinc picolinate,1
Dietary Supplement,zinc sulfate 220 mg,1
Drug,,1
Drug,-interferon nebulization,1
Drug,0.075% cetylpyridinium chloride,1
Drug,0.075% cetylpyridinium chloride (cpc),1
Drug,0.1% sodium hypochlorite,1
Drug,0.12% chg oral rinse,1
Drug,0.12% chlorhexidine gluconate,1
Drug,0.12% chlorhexidine gluconate mouth rinse,1
Drug,0.4ml inj syringe 0.4ml,1
Drug,0.5% povidone iodine,1
Drug,0.9% (w,1
Drug,0.9% (w/v) saline,1
Drug,0.9% normal saline,1
Drug,1% hydrogen peroxide,1
Drug,1% povidone iodine (pvp-i),1
Drug,1% w,1
Drug,1% w/v povidone-iodide,1
Drug,1.5-2% w,1
Drug,1.5-2% w/v hydrogen peroxide,1
Drug,1.5% hydrogen peroxide (h2o2),1
Drug,100 mg/ml virazole,1
Drug,1600 mg),1
Drug,21% ethanol,1
Drug,21% ethanol/essential oils,1
Drug,24h transdermal patch - 24 hour,1
Drug,3),1
Drug,400 mg,1
Drug,5% glucose,1
Drug,50 mg,1
Drug,50 mg/ml virazole,1
Drug,99mtc-pertechnetate aerosol,1
Drug,aat( alpha 1 antitrypsin),1
Drug,abatacept,1
Drug,abbv-2b04,1
Drug,abbv-47d11,1
Drug,abivertinib,1
Drug,abx464,1
Drug,"ace inhibitor, angiotensin receptor blocker",1
Drug,ace inhibitor/arb,1
Drug,ace inhibitors/calcium channel blockers,1
Drug,active comparator,1
Drug,adg20,1
Drug,adm03820,1
Drug,aerosolized dnase,1
Drug,agent-797,1
Drug,ak119,1
Drug,albuterol sulfate (mdi),1
Drug,albuterol sulfate (nebulizer),1
Drug,allogeneic,1
Drug,allogeneic mesenchymal stem cell,1
Drug,almitrine,1
Drug,"alpha-interferon alpha, abidol, ribavirin, buzhong yiqi plus",1
Drug,"alpha-interferon alpha, abidol, ribavirin, buzhong yiqi plus/minus formula, huhuang detoxicity paste, baimu qingre jiedu paste, fumigation/inhalation of vitamin c",1
Drug,"alpha-interferon, abidol, ribavirin, buzhong yiqi plus/minus formula, huhuang detoxicity paste, baimu qingre jiedu paste/5% glucose",1
Drug,"alpha-interferon, abidol, ribavirin, buzhong yiqi plus/minus formula, huhuang detoxicity paste, baimu qingre jiedu paste/high-dose vitamin c treatment",1
Drug,alpha one antitrypsin,1
Drug,alteplase,1
Drug,alvelestat,1
Drug,amiodarone,1
Drug,amlodipine,1
Drug,anakinra/osoc,1
Drug,anakinra/ruxolitinib,1
Drug,ang-3777,1
Drug,angiotensin,1
Drug,angiotensin-(1-7),1
Drug,angiotensin-converting enzyme inhibitors (ace-i)/angiotensin ii receptor blockers (arb),1
Drug,angiotensin ii,1
Drug,angiotensin ii receptor blockers,1
Drug,anise,1
Drug,anluohuaxian,1
Drug,anti-sars-cov-2 igy,1
Drug,antibiotic,1
Drug,anticoagulation agents (edoxaban and,1
Drug,anticoagulation agents (edoxaban and/or high dose lmwh),1
Drug,antirheumatic drugs,1
Drug,antithrombin,1
Drug,antithrombin / best available treatment,1
Drug,antithrombin iii,1
Drug,antroquinonol,1
Drug,any drug used to treat covid-19,1
Drug,apilimod dimesylate,1
Drug,apixaban 5mg,1
Drug,apl-9,1
Drug,aprepitant injectable emulsion,1
Drug,aprotinin,1
Drug,arb blocker,1
Drug,arbidol hydrochloride/interferon atomization,1
Drug,argatroban,1
Drug,art,1
Drug,artemether-lumefantrine (al),1
Drug,artemic,1
Drug,artemisia annua leaf,1
Drug,artesunate,1
Drug,artesunate-amodiaquine,1
Drug,asc09,1
Drug,asc09f/oseltamivir,1
Drug,asp,1
Drug,aspirin 25mg orally,1
Drug,asunercept 100mg,1
Drug,asunercept 25mg,1
Drug,asunercept 400mg,1
Drug,at-001,1
Drug,atazanavir,1
Drug,ati-450,1
Drug,atorvastatin / l-arginine / folic acid / nicorandil / nebivolol,1
Drug,atorvastatin 20 mg oral tablet,1
Drug,atovaquone,1
Drug,atovaquone/azithromycin,1
Drug,atr-002,1
Drug,autophagy inhibitor (gns651),1
Drug,auxora,1
Drug,avdoralimab,1
Drug,aviptadil,1
Drug,aviptadil/standard care,1
Drug,azd1222,1
Drug,azd1656,1
Drug,azithromycin / ivermectin / ribaroxaban / paracetamol,1
Drug,azithromycin / ribaroxaban / paracetamol,1
Drug,azoximer bromide,1
Drug,bardoxolone methyl,1
Drug,baricitinib/anakinra,1
Drug,bat / calcifediol,1
Drug,bcg-10 vaccine,1
Drug,bdb-001 injection,1
Drug,bemiparin sodium,1
Drug,bempegaldesleukin,1
Drug,berberine,1
Drug,best symptomatic treatment based on doctor recommendations),1
Drug,beta interferon,1
Drug,betadineâ© bucal 100 mg,1
Drug,betadineâ© bucal 100 mg/ml,1
Drug,bgb-dxp593,1
Drug,bgb dxp593,1
Drug,bge-175,1
Drug,bi 764198,1
Drug,bicalutamide 150 mg,1
Drug,bicalutamide 150 mg oral tablet,1
Drug,bio 300 oral suspension,1
Drug,bio101,1
Drug,bivalirudin,1
Drug,bld-2660,1
Drug,bms-986253,1
Drug,bno 1030,1
Drug,botulinum neurotoxin,1
Drug,bovhyaluronidase azoxymer,1
Drug,brain parenchyma biopsies,1
Drug,brazilian green propolis extract (epp-af),1
Drug,brensocatib,1
Drug,brexanolone,1
Drug,bridge therapy,1
Drug,brilacidin,1
Drug,bromhexine oral tablet and/or hydroxychloroquine tablet,1
Drug,btl-tml-covid,1
Drug,c21,1
Drug,calcifediol,1
Drug,calcium channel blockers,1
Drug,camostat mesylate,1
Drug,candesartan,1
Drug,cd24fc,1
Drug,cefditoren pivoxil 400mg,1
Drug,cerc-002,1
Drug,"cerebrospinal fluid sampling, meningeal",1
Drug,"cerebrospinal fluid sampling, meningeal/brain parenchyma biopsies",1
Drug,chemotherapy,1
Drug,chlorine dioxide,1
Drug,clarithromycin,1
Drug,clarithromycin 500mg,1
Drug,clevudine,1
Drug,clofazimine,1
Drug,cm4620-ie (injectable emulsion),1
Drug,colchicine 0.5 mg,1
Drug,colchicine 0.6 mg,1
Drug,colchicine pill,1
Drug,colchicine/herbal phenolic monoterpene fractions,1
Drug,colchicine/symptomatic treatment (paracetamol),1
Drug,collagen-polyvinylpyrrolidone,1
Drug,combined art,1
Drug,combined art/hydroxychloroquine,1
Drug,conestat alfa,1
Drug,continuation of ras blocker,1
Drug,control group (standard hospital treatment),1
Drug,control test,1
Drug,control treatment schedule,1
Drug,convalscent plasma,1
Drug,"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,/lopinavir/ritonavir)",1
Drug,"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,/lopinavir/ritonavir)/traditional chinese medicines (tcms) granules",1
Drug,coromec registry with ecl-19,1
Drug,corticosteroid alone,1
Drug,corticosteroid with,1
Drug,corticosteroid with/without colchicine,1
Drug,corticosteroids/derivatives,1
Drug,corvax,1
Drug,covid-19 group,1
Drug,covid-19 group (group i),1
Drug,covid-19 group (group ii),1
Drug,covid-19 treatment,1
Drug,cpi-006,1
Drug,cpi-006 1 mg,1
Drug,cpi-006 1 mg/kg / soc,1
Drug,cpi-006 2 mg,1
Drug,cpi-006 2 mg/kg / soc,1
Drug,crizanlizumab,1
Drug,cst-2: eidd-2801,1
Drug,cumin,1
Drug,d,1
Drug,d followed by enoxaparin,1
Drug,daclatasvir 200mg,1
Drug,dalcetrapib,1
Drug,danoprevir,1
Drug,danoprevir/ritonavir,1
Drug,dapansutrile capsules,1
Drug,das181,1
Drug,decitabine,1
Drug,deferoxamine,1
Drug,defibrotide 25 mg/kg 24 hours continuous infusion for 15 days,1
Drug,degarelix,1
Drug,deglycyrrhizinated licorice,1
Drug,derivatives,1
Drug,desidustat,1
Drug,dexamethasone 2 mg,1
Drug,dexamethasone 2 mg/ml,1
Drug,dexamethasone high dose,1
Drug,dexamethasone low dose,1
Drug,dexamethasone/hydroxychloroquine,1
Drug,dfv890,1
Drug,dietary supplement containing resistant starch,1
Drug,dimethyl fumarate,1
Drug,diovan,1
Drug,dipyridamole er 200mg,1
Drug,dipyridamole er 200mg/ aspirin 25mg orally/enterally/standard of care,1
Drug,discontinuation of ras blocker,1
Drug,disulfiram,1
Drug,dociparstat sodium,1
Drug,double-blind nt-i7,1
Drug,doxycyclin,1
Drug,doxycycline hcl,1
Drug,doxycyline,1
Drug,duact,1
Drug,dur-928,1
Drug,dutasteride 0.5 mg,1
Drug,dwj1248 with remdesivir,1
Drug,dwrx2003,1
Drug,ec-18,1
Drug,eculizumab,1
Drug,eltrombopag,1
Drug,emricasan,1
Drug,emtricitabine 200 mg oral tablet,1
Drug,emtricitabine/tenofovir,1
Drug,emtricitabine/tenofovir disoproxil,1
Drug,endothelial protocol,1
Drug,enisamium iodide,1
Drug,enoxaparin/lovenox,1
Drug,ensifentrine,1
Drug,enterally,1
Drug,enzalutamide,1
Drug,escin,1
Drug,estetrol monohydrate 15 mg,1
Drug,estradiol,1
Drug,estrogen therapy,1
Drug,etoposide,1
Drug,exo-cd24,1
Drug,experimental group,1
Drug,extract psidii guava,1
Drug,favipiravir / standard care,1
Drug,favipiravir/azithromycin,1
Drug,favipiravir/chloroquine,1
Drug,favipiravir/hydroxychloroquine,1
Drug,favipiravir/nitazoxanide,1
Drug,favipiravir/tocilizumab,1
Drug,favorable outcome,1
Drug,fisetin,1
Drug,fluoxetine,1
Drug,fluoxetine tablets,1
Drug,fluvoxamine maleate 100 mg [luvox],1
Drug,fondapariniux,1
Drug,formoterol,1
Drug,fotv,1
Drug,foy-305,1
Drug,fsd201,1
Drug,fx06,1
Drug,ganovo,1
Drug,ganovo/ritonavir//-interferon nebulization,1
Drug,gc4419,1
Drug,gimsilumab,1
Drug,gls-1200,1
Drug,gns561,1
Drug,group 1: rivaroxaban 20mg/d followed by enoxaparin/unfractionated heparin when needed,1
Drug,group apixaban,1
Drug,group hydroxychloroquine/apixaban,1
Drug,gx-19,1
Drug,gx-19n,1
Drug,gx-i7 vehicle,1
Drug,had5-sfusion,1
Drug,had5-sfusion/ n-etsd (oral capsule),1
Drug,heparin - prophylactic dosage,1
Drug,heparin - therapeutic dosage,1
Drug,herbal phenolic monoterpene,1
Drug,hesperidin,1
Drug,hfb30132a,1
Drug,high-dose vitamin c treatment,1
Drug,human recombinant interleukin 2,1
Drug,hydrocortisone,1
Drug,hydroxychloroquine / metabolic cofactor supplementation,1
Drug,hydroxychloroquine / oxygen,1
Drug,hydroxychloroquine / sorbitol,1
Drug,"hydroxychloroquine, lopinavir",1
Drug,"hydroxychloroquine, lopinavir/ritonavir/azithromycin/placebo (standard therapy)",1
Drug,hydroxychloroquine/clindamycin,1
Drug,hydroxychloroquine/doxycycline,1
Drug,hydroxychloroquine/lopinavir/ritonavir,1
Drug,hydroxychloroquine/placebo,1
Drug,hydroxyvitamin,1
Drug,hyperimmune immunoglobulin to sars-cov-2 (hivig),1
Drug,hyperpolarized xe129,1
Drug,ibudilast,1
Drug,icatibant,1
Drug,icosapent ethyl,1
Drug,icosapent ethyl (ipe),1
Drug,idoine complex,1
Drug,ifx-1,1
Drug,igiv,1
Drug,il-12 plasmid,1
Drug,imatinib mesylate intravenous solution,1
Drug,immunoglubulins,1
Drug,immunosuppressive,1
Drug,immunosuppressive agents,1
Drug,inb03,1
Drug,indian costus,1
Drug,indomethacin,1
Drug,inhalation of vitamin c,1
Drug,inhaled type i interferon,1
Drug,inm005,1
Drug,insulin,1
Drug,interferon alfa,1
Drug,intermediate dose enoxaparin/ unfractionated heparin,1
Drug,intramuscular injection,1
Drug,intranasal ivermectin spray,1
Drug,intravenous drug,1
Drug,irl201104,1
Drug,isavuconazonium injection [cresemba],1
Drug,isis 721744,1
Drug,isoflurane inhalant product,1
Drug,isoquercetin,1
Drug,itolizumab,1
Drug,iv tocillizumab (tcz),1
Drug,ivermectin (iver pâ®) arm will receive ivm 600 âµg,1
Drug,ivermectin (iver pâ®) arm will receive ivm 600 âµg / kg once daily/standard care. control arm will receive standard care.,1
Drug,ivermectin / doxycycline,1
Drug,ivermectin / doxycycline / placebo,1
Drug,ivermectin / iota-carrageenan,1
Drug,ivermectin / placebo,1
Drug,ivermectin 3 mg,1
Drug,"ivermectin 5 mg/ml oral solution, aspirin 250 mg tablets",1
Drug,ivermectin oral tablets,1
Drug,ivermectin oral tablets/sublingual waffles,1
Drug,ivermectin pill,1
Drug,ivermectin powder,1
Drug,ivermectin/doxycycline,1
Drug,ivermectin/doxycyline,1
Drug,ivig,1
Drug,kaletra,1
Drug,kaletra/beta interferon,1
Drug,ketamine,1
Drug,ketotifen,1
Drug,kg 24 hours continuous infusion for 15 days,1
Drug,kg once daily,1
Drug,l-arginine,1
Drug,l-citrulline,1
Drug,lambda 180 mcg s.c,1
Drug,lanadelumab,1
Drug,late dexamethazone,1
Drug,lau-7b,1
Drug,leaf-4l6715,1
Drug,levamisole,1
Drug,levamisole / budesonide/formoterol,1
Drug,levilimab,1
Drug,liberase enzyme,1
Drug,lidocaine 2%,1
Drug,linagliptin,1
Drug,linagliptin 5 mg,1
Drug,liposomal,1
Drug,lmwh,1
Drug,lopinavir 200 mg,1
Drug,lopinavir 200 mg / ritonavir 50 mg [kaletra],1
Drug,lopinavir/ ritonavir/remdesivir combination,1
Drug,lopinavir/ritonavir / hydoxychloroquine,1
Drug,lopinavir/ritonavir 200 mg-50 mg oral tablet,1
Drug,losartan 50 mg,1
Drug,losartan 50 mg/spironolactone 25 mg pillules oral use,1
Drug,losmapimod,1
Drug,lovenox,1
Drug,low-molecular-weight heparin,1
Drug,low dose low molecular weight heparin,1
Drug,low dose low molecular weight heparin/placebo,1
Drug,low dose prednisolone,1
Drug,low molecular weight heparin as standard of care treatment,1
Drug,lsalt peptide,1
Drug,lucinactant,1
Drug,ly3127804,1
Drug,lyt-100,1
Drug,m-m-r ii â® vaccine,1
Drug,management of covid-19,1
Drug,mas825,1
Drug,masitinib,1
Drug,medium dose prednisolone,1
Drug,mefloquine,1
Drug,melatonin intravenous,1
Drug,melphalan,1
Drug,meplazumab,1
Drug,merimepodib,1
Drug,metabolic cofactor supplementation,1
Drug,metenkefalin,1
Drug,metenkefalin / tridecactide,1
Drug,metformin,1
Drug,metformin extended release oral tablet,1
Drug,metformin glycinate,1
Drug,methotrexate-lde phase 1,1
Drug,methotrexate-lde phase 2,1
Drug,methylene blue/ vitamin c/n-acetyl cysteine,1
Drug,methylprednisolone injectable product,1
Drug,methylprednisolone injection,1
Drug,"minus formula, huhuang detoxicity paste, baimu qingre jiedu paste, fumigation",1
Drug,ml intravenous solution [actemra]_#1,1
Drug,ml intravenous solution [actemra]_#1 (2 doses),1
Drug,"ml oral solution, aspirin 250 mg tablets",1
Drug,ml prefilled syringe [kineret],1
Drug,modafinil,1
Drug,molgramostim nebuliser solution,1
Drug,molixan,1
Drug,mometasone furoate nasal spray,1
Drug,monalizumab,1
Drug,montelukast,1
Drug,montmorrillonite,1
Drug,mr,1
Drug,mr/m-m-r ii â® vaccine,1
Drug,mrg-001,1
Drug,mrx-4dp0004,1
Drug,mstt1041a,1
Drug,mucodentol,1
Drug,n-etsd (oral capsule),1
Drug,naproxen,1
Drug,nasal irrigation,1
Drug,nbt-nm108,1
Drug,nebivolol,1
Drug,nebulised heparin,1
Drug,nebulised recombinant tissue-plasminogen activator (rt-pa),1
Drug,nebulised unfractionated heparin (ufh),1
Drug,nebulized furosemide,1
Drug,nebulized saline,1
Drug,niclosamide / camostat,1
Drug,niclosamide oral tablet,1
Drug,niclosamide suspension,1
Drug,nicorandil,1
Drug,nicotine 7 mg,1
Drug,nicotine 7 mg/ 24h transdermal patch - 24 hour,1
Drug,nicotine patch,1
Drug,nigella sativa,1
Drug,nigella sativa / black cumin,1
Drug,nigella sativa seed,1
Drug,nintedanib,1
Drug,nintedanib 150 mg [ofev],1
Drug,nitazoxanide/atazanavir/ritonavir,1
Drug,"nitric oxide lozenges, 30 mg",1
Drug,nitroglycerin,1
Drug,nk-1r antagonist,1
Drug,nk cells,1
Drug,no-immunosuppressive,1
Drug,non-acei,1
Drug,non-acei/arb,1
Drug,normal saline intranasal,1
Drug,nox66,1
Drug,np-120 (ifenprodil),1
Drug,nuvastatic,1
Drug,observational,1
Drug,octagam,1
Drug,octaplas,1
Drug,olokizumab,1
Drug,omega 3/nigella sativa oil,1
Drug,omega 3/nigella sativa oil/anise seed capsule,1
Drug,omega 3/nigella sativa oil/deglycyrrhizinated licorice,1
Drug,omega 3/nigella sativa oil/indian costus,1
Drug,omega 3/nigella sativa oil/quinine pills,1
Drug,omeprazole,1
Drug,op-101,1
Drug,open label bss (pepto bismol),1
Drug,ophtamesone,1
Drug,or high dose lmwh),1
Drug,oral,1
Drug,oral ivermectin,1
Drug,ortd-1 high dose,1
Drug,ortd-1 low dose,1
Drug,ortd-1 mid dose,1
Drug,oseltamivir 75mg,1
Drug,ozanimod,1
Drug,p2et (caesalpinia spinosa extract),1
Drug,p2y12,1
Drug,pacritinib,1
Drug,pamrevlumab,1
Drug,part 1 - tl-895,1
Drug,part 2 - tl-895,1
Drug,part a,1
Drug,part a/b: placebo,1
Drug,part a: upamostat 200 mg,1
Drug,part a: upamostat 400 mg,1
Drug,part b: upamostat 200,1
Drug,part b: upamostat 200/400 mg,1
Drug,"patch, nicotine",1
Drug,patients with the treatment agains covid19,1
Drug,pemziviptadil (pb1046),1
Drug,pentaglobin,1
Drug,pentoxifylline,1
Drug,pf-06650833,1
Drug,pf-07304814,1
Drug,phr160 spray,1
Drug,piclidenoson,1
Drug,pioglitazone,1
Drug,pioglitazone 30 mg,1
Drug,pioglitazone 45 mg,1
Drug,piperacillin,1
Drug,piperacillin/tazobactam,1
Drug,placebo / soc,1
Drug,placebo/control,1
Drug,pln-74809,1
Drug,polyoxidonium,1
Drug,poractant alfa,1
Drug,povidone,1
Drug,prazosin,1
Drug,prednisone tablet,1
Drug,progesterone,1
Drug,prophylactic,1
Drug,prophylaxis,1
Drug,propofol,1
Drug,ptc299,1
Drug,pulmozyme/ recombinant human deoxyribonuclease (rh-dnase),1
Drug,pyridostigmine bromide,1
Drug,pyronaridine-artesunate (pa),1
Drug,quercetin,1
Drug,quinine,1
Drug,r tablets,1
Drug,ramipril,1
Drug,rayaldee 30mcg extended-release (er) capsule,1
Drug,razuprotafib,1
Drug,razuprotafib subcutaneous solution,1
Drug,rbt-9 (90 mg),1
Drug,rdv,1
Drug,recombinant human plasma gelsolin (rhu-pgsn),1
Drug,recommended treatment schedule,1
Drug,rejuveinix (rjx) active comparator,1
Drug,remdesivir-hu,1
Drug,remdesivir combination,1
Drug,renin-angiotensin system inhibitors,1
Drug,reparixin,1
Drug,"resp301, a nitric oxide generating solution",1
Drug,resveratrol,1
Drug,retrospective case-control analysis,1
Drug,rh-dnase,1
Drug,rhace2,1
Drug,rhdnase i,1
Drug,rhtpo,1
Drug,rintatolimod,1
Drug,ritonavir 200 mg-50 mg oral tablet,1
Drug,ritonavir 50 mg [kaletra],1
Drug,ritonavir/oseltamivir,1
Drug,rivaroxaban 15mg tab,1
Drug,rlf-100 (aviptadil),1
Drug,rnapc2,1
Drug,saline/standard care,1
Drug,sar443122,1
Drug,sarilumab prefilled syringe,1
Drug,sars-cov-2 vaccine,1
Drug,senicapoc,1
Drug,sessions,1
Drug,sildenafil,1
Drug,sildenafil citrate,1
Drug,simvastatin,1
Drug,single high dose vitamin d,1
Drug,sirukumab,1
Drug,soc / ifx-1,1
Drug,soc / intravenous famotidine,1
Drug,sodium chloride,1
Drug,sofosbuvir 400 mg,1
Drug,sofosbuvir 400 mg/daclatasvir 200mg,1
Drug,sofosbuvir ledipsavir,1
Drug,sorbitol,1
Drug,spironolactone 25 mg pillules oral use,1
Drug,standard of care (soc)/colchicine/rosuvastatin,1
Drug,standard of care thromboprophylaxis,1
Drug,standard prophylactic dose enoxaparin,1
Drug,standard prophylactic dose enoxaparin/ unfractionated heparin,1
Drug,standard therapy protocol (stp),1
Drug,standard treatment of covid-19,1
Drug,statins,1
Drug,sti-5656,1
Drug,sublingual methylene blue,1
Drug,sublingual micro-dose ketamine,1
Drug,sublingual waffles,1
Drug,sulfur hexafluoride lipid-type a microspheres,1
Drug,sulodexide,1
Drug,supportive/symptomatic treatment,1
Drug,surfactant,1
Drug,symbicort,1
Drug,symptomatic drugs,1
Drug,symptomatic treatment,1
Drug,symptomatic treatment (paracetamol,1
Drug,symptomatic treatment (paracetamol),1
Drug,symptomatic treatment (paracetamol/best symptomatic treatment based on doctor recommendations),1
Drug,synthetic neutralising antibodies,1
Drug,t3 solution,1
Drug,tafenoquine oral tablet,1
Drug,tazobactam,1
Drug,tcm,1
Drug,td139,1
Drug,telmisartan 40mg oral tablet,1
Drug,tenecteplase,1
Drug,tenofovir,1
Drug,tenofovir disoproxil/emtricitabine,1
Drug,tenofovir disoproxyl fumarate 300 mg,1
Drug,tenofovir disoproxyl fumarate 300 mg oral tablet,1
Drug,tenofovir disoproxyl fumarate 300 mg/emtricitabine 200 mg oral tablet,1
Drug,tetracycline hydrochloride 3%,1
Drug,tetrandrine,1
Drug,theraputic heparin,1
Drug,thymosin,1
Drug,tirofiban,1
Drug,tj003234,1
Drug,tm5614,1
Drug,tnkase,1
Drug,tociliuzumab,1
Drug,tocilizumab 20 mg/ml intravenous solution [actemra]_#1,1
Drug,tocilizumab 20 mg/ml intravenous solution [actemra]_#1 (2 doses),1
Drug,tradipitant,1
Drug,traditional chinese medicine,1
Drug,tranexamic acid,1
Drug,trans sodium crocetinate,1
Drug,transfusion of sars-cov-2 convalescent plasma.,1
Drug,transfusion of standard plasma.,1
Drug,treamid,1
Drug,treatment,1
Drug,treatment as usual vitamin d,1
Drug,treatment/prophylaxis,1
Drug,triazavirin (riamilovir),1
Drug,tridecactide,1
Drug,trimetazidine,1
Drug,trimodulin,1
Drug,trimoxazole,1
Drug,txa127,1
Drug,type ii diabetes mellitus,1
Drug,type ii diabetes mellitus/covid-19 group (group ii),1
Drug,umifenovir,1
Drug,unfractionated heparin iv,1
Drug,unfractionated heparin sc,1
Drug,uni911 inhalation,1
Drug,usual practice / symbicort rapihaler,1
Drug,uttr1147a,1
Drug,uvc irradiation,1
Drug,v hydrogen peroxide,1
Drug,v povidone-iodide,1
Drug,v) saline,1
Drug,vadadustat,1
Drug,vb-201,1
Drug,vb-201 / standard of care,1
Drug,ventaprost (inhaled epoprostenol delivered via a dedicated delivery system),1
Drug,verapamil,1
Drug,veru-111,1
Drug,vib7734,1
Drug,vir-7831,1
Drug,virgin coconut oil (vco),1
Drug,vitamin c 500 mg oral tablet,1
Drug,vitamin c tablets,1
Drug,vitamin e,1
Drug,voclosporin,1
Drug,water,1
Drug,wfi water nebulization,1
Drug,wharton's jelly derived mesenchymal stem cells.,1
Drug,without colchicine,1
Drug,xav-19,1
Drug,xc221,1
Drug,xcel-umc-beta,1
Drug,xuanfei baidu granules,1
Drug,zanubrutinib,1
Drug,zavegepant (bhv-3500),1
Drug,zidovudine,1
Drug,zilucoplan,1
Drug,zithromax,1
Genetic,assessment tests,1
Genetic,blood sample,1
Genetic,complete thrombophilic profile testing by multiplex pcr,1
Genetic,covid-19 androgen sensitivity test (covast),1
Genetic,covid-19 diagnostic,1
Genetic,covid-19 diagnostic/assessment tests,1
Genetic,d region,1
Genetic,dalargin,1
Genetic,genetic,1
Genetic,massive parallel sequencing of host genome,1
Genetic,next generation sequencing (ngs) analysis,1
Genetic,sars-cov-2 viral composition,1
Genetic,sequencing,1
Genetic,single-nucleotide polymorphisms (snp) within the tcra,1
Genetic,single-nucleotide polymorphisms (snp) within the tcra/d region,1
Genetic,t-cell receptor,1
Genetic,whole exome sequencing,1
Other,"""calm"" is a mindfulness meditation mobile app",1
Other,),1
Other,[timp-2]*[igfbp-7],1
Other,0.07% cetylpyridinium chloride (cpc) in mouthwash,1
Other,"12.7% fio2, hypercapnia 7% co2, inspiratory mechanical constraint",1
Other,2 post-mortem transcutaneous lung biopsies (1 anterior ; 1 posterior) using anatomical landmarks,1
Other,25 post non-icu patients,1
Other,40ml blood sample,1
Other,4c mortality score,1
Other,6 minutes walk test,1
Other,6 months later,1
Other,6 weeks after delivery,1
Other,a - samples collected along routine care samples only,1
Other,a short video intervention,1
Other,a survey of 60 questions was created through the internet-based 'google forms surveys' site.,1
Other,a vignette intervention,1
Other,"ä±t will be compared pain, sleep, fatigue, physical activity level",1
Other,"ä±t will be compared pain, sleep, fatigue, physical activity level/quality of life/questioning exercise habits before/after the covid-19 outbreak in patients with behã§et/fmf.",1
Other,ace/arb,1
Other,active covid-19 disease,1
Other,activity,1
Other,activity list,1
Other,"adaptive immune response, complement activation,",1
Other,additional,1
Other,additional/minimal collection of products of the human body carried out during a sample for standard of care,1
Other,adjunctive therapies,1
Other,admission to icu for covid-19,1
Other,aerobic exercises,1
Other,aerobic training,1
Other,after-each-case room disinfection,1
Other,after covid-19 pandemic,1
Other,after the covid-19 outbreak in patients with behã§et,1
Other,ai algorithm,1
Other,airwave oscillometry,1
Other,airway pressure release ventilation,1
Other,albumine,1
Other,alcohol mouthwash (listerine) (d) mouth rinse with the solution provided,1
Other,all treatment about covid-2019,1
Other,alternate nostril breathing,1
Other,ambulation,1
Other,analog scale,1
Other,analysis of blood samples,1
Other,"analysis of cytokine response, innate",1
Other,"analysis of cytokine response, innate/adaptive immune response, complement activation,/serum neurofilaments as a marker of neurological damage.",1
Other,anger message,1
Other,antibody tests,1
Other,antidiabetic treatment,1
Other,antithrombotic therapy (anticoagulant and,1
Other,antithrombotic therapy (anticoagulant and/or antiplatelet) before admission for covid19,1
Other,anxiety,1
Other,anxiety questionnaire,1
Other,anxiety),1
Other,appendectomy,1
Other,apps,1
Other,ards,1
Other,ards/covid19 treatments,1
Other,ardsnet,1
Other,ashmolean website,1
Other,assembled mask,1
Other,assessing impact of covid19,1
Other,assessment of postnatal depression using the the edinburgh questionnaire between 4,1
Other,assessment of postnatal depression using the the edinburgh questionnaire between 4/6 weeks after delivery,1
Other,assessment of the sequelae after hospitalization for sars-cov-2,1
Other,at risk for covid-19 infection,1
Other,attendance by ambulance crew,1
Other,auricular stimulation,1
Other,autopsy,1
Other,baseline,1
Other,baseline blood sample,1
Other,baseline message,1
Other,baseline/during hospitalization blood samples,1
Other,beck depression inventory (bdi),1
Other,bereavement virtual support group,1
Other,betadine (c) mouth rinse with the solution provided,1
Other,big five inventory (bfi) scale,1
Other,biochemical analysis,1
Other,biocollection,1
Other,biological sample/clinical data collection,1
Other,biospecimen collection,1
Other,blood d-dimer assay,1
Other,blood draw,1
Other,blood sample analyses,1
Other,blood sample/data record,1
Other,"blood tests sputum, nasal lavage",1
Other,"blood tests sputum, nasal lavage/brushing",1
Other,blood/derivatives,1
Other,body position change,1
Other,"breathing exercise, intensive spirometry use, supported cough, progressive mobilisation",1
Other,"breathing exercise, intensive spirometry use, supported cough, progressive mobilisation/ambulation",1
Other,brief cope scale,1
Other,brief psychiatric rating scale,1
Other,brushing,1
Other,building of the classification model,1
Other,by computer consultation,1
Other,by computer consultation. quantitative,1
Other,cam-icu 7 score,1
Other,cardiac,1
Other,cardiac surgery,1
Other,cardiac/electrodermal recordings,1
Other,cardiology clinical consultations,1
Other,cardiopulmonary resuscitation,1
Other,cardiovascular magnetic resonance (cmr) imaging,1
Other,care as usual,1
Other,care modalities,1
Other,care modalities. quantitative,1
Other,care modalities. quantitative/qualitative approaches to analysis,1
Other,caring contacts without an introductory phone call (cc),1
Other,caring contacts/introductory phone call (cc/),1
Other,case fatality rate,1
Other,cash transfer,1
Other,certified cloth face mask,1
Other,certified cloth face mask/preventive information,1
Other,chart review,1
Other,check-list including lung ultrasound,1
Other,chemokines profiles of patients with dexmedetomidine administration,1
Other,chest ct,1
Other,chest physiotherapy post-covid19,1
Other,chiropractic care,1
Other,chiropractic care (more than one visit),1
Other,chiropractic care (one visit),1
Other,chlorhexidine gluconate (a) mouth rinse with the solution provided,1
Other,chlorine dioxide,1
Other,chloroquine,1
Other,chloroquine/hydroxychloroquine,1
Other,chx0.12,1
Other,chx0.12/cpc0.05 oral rinse (perioaidactive control),1
Other,cig axial,1
Other,cig tilted,1
Other,clinical data collection,1
Other,clinical diagnosis of covid-19 by a health care professional,1
Other,clinical examination,1
Other,clinical interview,1
Other,clinical observation,1
Other,clinical outcomes in elderly patients with covid-19.,1
Other,clinical testing of subjects,1
Other,"clinical, functional",1
Other,"clinical, functional/radiological lung involvement evolution",1
Other,"clinical, laboratory",1
Other,"clinical, laboratory/imaging characteristics of pneumonia",1
Other,closed face shield with surgical face mask use,1
Other,cns magnetic resonance imaging (mri) imaging,1
Other,"cognitive behavior therapy (cbt), specifically using the facing your fears (fyf) curriculum",1
Other,cognitive behavioural group therapy for perinatal anxiety,1
Other,cognitive testing,1
Other,colgate periogard mouthwash,1
Other,colgate peroxyl mouthwash,1
Other,colgate total mouthwash,1
Other,"collection of blood, salivary",1
Other,"collection of blood, salivary/nasopharyngeal samples.",1
Other,communication type,1
Other,community-driven messages to promote covid-19 testing,1
Other,community health worker support,1
Other,community health workers.,1
Other,community interest message,1
Other,community mask,1
Other,comparative observational cohort study,1
Other,compare the difference in respiratory rate between h0,1
Other,compassion exercises,1
Other,compassion focused intervention,1
Other,completion of post telemedicine encounter survey,1
Other,completion of pre-pandemic survey,1
Other,completion of survey after peak of pandemic,1
Other,complex diagnostic panel,1
Other,comprehensive treatment,1
Other,connor-davidson resilience scale 10 items (cd-risc 10),1
Other,continuation of acei,1
Other,continuation of acei/arb,1
Other,continued self-enhancement (enhance) for covid-19,1
Other,contrast-enhanced mri,1
Other,control blend,1
Other,control group - waiting list,1
Other,control group quality of life assessment,1
Other,control message,1
Other,control patients,1
Other,convalescent plasma with antibody against sars-cov-2.,1
Other,"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,/lopinavir/ritonavir)/traditional chinese medicines (tcms) granules",1
Other,"coronavirus anxiety scale , covid-19 phobia scale",1
Other,coronavirus disease 2019,1
Other,covicu,1
Other,covid-19 / patients,1
Other,covid-19 convalescent plasma (cp),1
Other,covid-19 experience surveys,1
Other,covid-19 facility,1
Other,covid-19 infection status,1
Other,covid-19 monitoring using wearable sensors,1
Other,covid-19 monitoring using wearable sensors/smartphone technology,1
Other,covid-19 pneumonia,1
Other,covid-19 positive via testing,1
Other,covid-19 survey,1
Other,covid-19 treatments,1
Other,covid-19 vaccine hesitancy associated factors,1
Other,covid-19 vaccine hesitancy scale in rheumatic diseases,1
Other,covid-19/ observational,1
Other,covid-19/intensive care,1
Other,covid 19 impact,1
Other,covid 19 self-questionnaire,1
Other,covid rehabilitation program for the elderly (core),1
Other,covid watch,1
Other,covid19 treatments,1
Other,cpc0.05 oral rinse (perioaidactive control),1
Other,cries 13 questionnaire,1
Other,cross-sectional observational study,1
Other,cross-sectional study investigating the association of npis with mental health,1
Other,cross-sectional survey,1
Other,cross sectional e-survey on surgeons exposed to any educational intervention,1
Other,cross sectional study using scientifically validated psychometric scales,1
Other,cryo lung biopsies,1
Other,cupping,1
Other,current care per ucla treating physicians,1
Other,daily room disinfection,1
Other,daily syndromic surveillance,1
Other,dass-21 instrument (depression,1
Other,dass-21 instrument (depression/anxiety),1
Other,dass questionnaire,1
Other,data collecting,1
Other,data collection from blood draw,1
Other,data collection from lumbar puncture,1
Other,data collection from medical files,1
Other,data collection up to 1 year,1
Other,data collection/clinical testing of subjects,1
Other,data monitoring for 48h within the first 24 hours of admission for covid-19,1
Other,"data research, database analysis",1
Other,death with routine,1
Other,decision science-based design,1
Other,decision tool for clinicians,1
Other,dect,1
Other,deep breathing training,1
Other,demographic characteristics,1
Other,depression scale,1
Other,"depression, anxiety",1
Other,"depression, anxiety/stress scale",1
Other,derivatives.,1
Other,description of groups caracteristics,1
Other,diabetes type 2,1
Other,diagnostic test,1
Other,diet tracking,1
Other,"dietary counselling on food groups according to iyc feeding practices, who",1
Other,differences in triage,1
Other,difficulties lived by disabled children's parents in the period of covid-19 pandemic,1
Other,dig axial,1
Other,dig tilted,1
Other,digital cardiac counseling,1
Other,digital storytelling intervention,1
Other,discontinuation of acei,1
Other,discontinuation of acei/arb,1
Other,distance learning,1
Other,distilled water with the same colorant as the experimental product,1
Other,dlco,1
Other,doppler echo,1
Other,drugs,1
Other,drugs/supportive care,1
Other,during covid-19 pandemic,1
Other,during hospitalization blood samples,1
Other,"during the pandemic, the patient's job status, physical activity conditions, pain status",1
Other,dysautonomia,1
Other,dysphagia handicap index (dhi),1
Other,eat-26 questionnaire,1
Other,ecg-holter,1
Other,echocardiography,1
Other,economic benefit message,1
Other,economic freedom message,1
Other,edinburgh postnatal depression scale (edps),1
Other,educational program (cartoon),1
Other,"educational, culturally appropriate covid-19 messages",1
Other,eit-group,1
Other,electrodermal recordings,1
Other,electrolytes,1
Other,elmo project at covid-19: study in humans,1
Other,embarrassment message,1
Other,emergency general surgical admissions,1
Other,endoscopic management according to standard of care,1
Other,endotracheal intubation,1
Other,enduring happiness,1
Other,enduring happiness/continued self-enhancement (enhance) for covid-19,1
Other,epds (edinburgh postnatal depression scale),1
Other,epic risk score display,1
Other,epidemiological,1
Other,epidemiological/demographic characteristics,1
Other,epidemiology of admissions,1
Other,eproms assessment,1
Other,equipment with smartwatch throughout hospital stay on the general ward,1
Other,essence oils,1
Other,essential oil blend,1
Other,evaluate hacor score effectivity in this patients,1
Other,evaluation of skin microvascular flow,1
Other,evaluation of skin microvascular flow/reactivity,1
Other,evaluation of the epidemiological characteristics of coronavirus infection (sars-cov-2),1
Other,evaluation of the ferritin,1
Other,exercise booklet,1
Other,exercise program,1
Other,exercise training,1
Other,experimental: questionnaire without precaution information,1
Other,experts consensus,1
Other,exposure to covid19,1
Other,exposure to disinfectants during the coronavirus pandemic,1
Other,exposure to the dutch measures due to the covid-19 pandemic.,1
Other,extended post anaesthetic care in pacu,1
Other,extra-cvd virtual care,1
Other,eye movement desensitisation,1
Other,eye movement desensitisation/reprocessing recent traumatic event protocol,1
Other,farmalarm,1
Other,fecal sample,1
Other,fenofibrate,1
Other,fenofibrate/fenofibric acid,1
Other,fenofibric acid,1
Other,ffp2 respirator,1
Other,ffp3 respirator,1
Other,fibrin generation markers assays,1
Other,fibromyalgia impact questionnaire,1
Other,file inquiry,1
Other,fluorescein,1
Other,fmf.,1
Other,follow-up of patients with covid-19,1
Other,follow-up phone call,1
Other,follow-up visit,1
Other,follow up,1
Other,follow up calls,1
Other,food diary,1
Other,further processing of health data,1
Other,gad-7 (7-item generalized anxiety disorder),1
Other,gad-7 (general anxiety disorder) scale,1
Other,gad-7 (generalized anxiety disorder) scale (during containment),1
Other,gad-7 (generalized anxiety disorder) scale (post containment),1
Other,gad-7 general anxiety disorder scale,1
Other,gas exchanges at different peep,1
Other,gastroscopy in transnasal techique,1
Other,general public cohort,1
Other,genetic analyses.,1
Other,global survey,1
Other,glucose control,1
Other,glucose control/sensor usage,1
Other,glycaemic levels,1
Other,glycosylated ferritin by standard approved serological tests,1
Other,gm-csf,1
Other,"gps reports of potential patient safety incidents, non-covid-19 related",1
Other,grandiosity subscales,1
Other,grocery store gift cards,1
Other,group 1,1
Other,group a (sample collection),1
Other,group b (sample collection),1
Other,group1,1
Other,guilt message,1
Other,gustatory tests,1
Other,h12 of the initiation of morphine between the control,1
Other,health enhancement program,1
Other,health questionnaire,1
Other,healthy lifestyle advise,1
Other,hemodynamics changes at different peep,1
Other,heparin,1
Other,high-intensity aerobic training with high protein diet,1
Other,high peep with end inspiratory pause,1
Other,high peep without end inspiratory pause,1
Other,home-cov rule implementation,1
Other,home-use test,1
Other,home care monitoring,1
Other,home exercise,1
Other,home sample collection of concerning mole with physician supervision,1
Other,hospital acquired infection,1
Other,hospital admission,1
Other,hospital anxiety,1
Other,hospital anxiety/depression scale,1
Other,hospitalisation for sars-cov2 infection,1
Other,"hospitalisation, necessity of icu, mortality rate, lung involvement",1
Other,hospitalization for premature birth,1
Other,hospitalized children with covid19,1
Other,hospitalized patients for covid-19 infection,1
Other,host genotype,1
Other,host immune factors,1
Other,"human coach first, then virtual assistant",1
Other,human milk donors,1
Other,hydrogen peroxide (b) mouth rinse with the solution provided,1
Other,hydroxychloroquine,1
Other,hypertension,1
Other,hypothermia via cooling machine- arctic sun 5000,1
Other,hypoxia : 14.3,1
Other,"hypoxia : 14.3/12.7% fio2, hypercapnia 7% co2, inspiratory mechanical constraint",1
Other,ice swimming,1
Other,icu recovery,1
Other,icu recovery / physical therapy,1
Other,identification of genetic variants,1
Other,ier-r (posttraumatic stress),1
Other,igm/igg rapid test,1
Other,imaging characteristics of pneumonia,1
Other,immunoglobulin,1
Other,impact event score,1
Other,impact of event scale-revised,1
Other,in-hospital mortality rate,1
Other,individualized-chinese herbal medicine,1
Other,infectious disease,1
Other,infectious disease/cardiology clinical consultations,1
Other,inflammatory cytokines,1
Other,inflammatory cytokines/chemokines profiles of patients with dexmedetomidine administration,1
Other,informed consent,1
Other,inhalation of 5% sodium chloride,1
Other,"inhalation of 8,4% sodium bicarbonate",1
Other,inhalation of n-acetylcysteine,1
Other,inspiratory muscle training,1
Other,integrated clinical evaluation,1
Other,intensive care,1
Other,intensive care unit admission ratio,1
Other,intervention group_rehabilitation program,1
Other,interventional groups,1
Other,interview by psychologists,1
Other,intestinal microbiota,1
Other,introductory phone call (cc,1
Other,invasive mechanical ventilation,1
Other,investigation of smell,1
Other,investigation of smell/taste disorders,1
Other,investigation of the prevalence of test positivity,1
Other,its,1
Other,ivermectin impregnated mask,1
Other,ivermectin/deamethisone/aspirin,1
Other,ivermectin/deamethisone/exoparin,1
Other,kb109 / self supportive care,1
Other,ketogenic diet,1
Other,kinesiotherapy protocol,1
Other,laboratory test positive for sars-cov-2 virus,1
Other,labs,1
Other,laughter theraphy,1
Other,let it out (lio)-c,1
Other,leukapheresis,1
Other,lifestyle habits,1
Other,liver,1
Other,loneliness,1
Other,lopinavir,1
Other,low-intensity aerobic training,1
Other,low peep - fio2 high,1
Other,low peep - fio2 low,1
Other,lung ct scan analysis in covid-19 patients,1
Other,lung mechanics at different peep,1
Other,lung ultrasound,1
Other,lung ultrasound (lus),1
Other,machine learning,1
Other,machine learning/ai algorithm,1
Other,magnetic resonance spectroscopy (mrs).,1
Other,maintenance,1
Other,management strategy of outpatient with mild to moderate sars-cov-2 pneumonia,1
Other,mask,1
Other,"maternal attachment, edinburgh depression scoring",1
Other,"maternal attachment, edinburgh depression scoring/postpartum anxiety scale scores",1
Other,maternal sars-cov-2 infection,1
Other,maternal stress,1
Other,maximal effort test,1
Other,measurement of circulating sflt1 concentration,1
Other,measurement of respiratory muscle force,1
Other,mechanical trombectomy,1
Other,media intervention,1
Other,medical follow-up,1
Other,medical record review - inpatient treatment,1
Other,mental health student,1
Other,mesenchymal stromal cell-based therapy,1
Other,mesenchymal stem cells,1
Other,methylene-blue photodisinfection,1
Other,mhealth assessments,1
Other,microscopy of defined brain regions on autopsy specimens,1
Other,mindfulness,1
Other,minimal collection of products of the human body carried out during a sample for standard of care,1
Other,"ml oral solution, dexamethasone 4-mg injection, aspirin 250 mg tablets",1
Other,"ml oral solution, dexamethasone 4-mg injection, enoxaparin injection. inpatient treatment with mechanical ventilation in icu.",1
Other,mmrc (modified medical research council) dyspnea scale,1
Other,mobile internet survey on self-test,1
Other,model building,1
Other,model validation,1
Other,moderate intensity aerobic exercises,1
Other,modification,1
Other,modified rankin score,1
Other,monitoring,1
Other,monitoring for aggravation,1
Other,mortality,1
Other,motivational messages,1
Other,moxibustion,1
Other,moxibustion/cupping,1
Other,mr-pro-adm,1
Other,mri,1
Other,multisystem inflammatory syndrome in children (mis-c),1
Other,n,1
Other,n/a - samples collected along routine care samples only,1
Other,na (no intervention),1
Other,nasal,1
Other,nasal lavage,1
Other,naser al-husban,1
Other,nasopharyngeal samples.,1
Other,nasopharynx,1
Other,ncapp,1
Other,nebulized sterile saline,1
Other,neuromuscular electrical stimulation,1
Other,neutral writing control,1
Other,new ppe,1
Other,newborns,1
Other,nhanes smell,1
Other,nhanes smell/taste tests,1
Other,no intervention-mechanistic study,1
Other,no intervention (survey study for medical doctors).,1
Other,no intervention as it is an observational study,1
Other,"no intervention will be administered, this is a retrospective observational study.",1
Other,no intervention. method study. psychometric testing,1
Other,no intervention; observational study,1
Other,no interventional study,1
Other,"no interventions performed. just collecting data, blood samples",1
Other,"no interventions performed. just collecting data, blood samples/post-mortem biopsies.",1
Other,no research related technology based social interactions,1
Other,no special intervention,1
Other,non,1
Other,non-hospitalization procedures,1
Other,non-interventional study,1
Other,non intervention,1
Other,non interventional study,1
Other,non invasive visual acuity testing,1
Other,none - na,1
Other,"none, this study is observational",1
Other,not applicable (na),1
Other,not applicable (observational study),1
Other,not bravery message,1
Other,"nursing care to reduce anxiety, fear",1
Other,"nursing care to reduce anxiety, fear/loneliness",1
Other,nutritional assessment,1
Other,nutritional intervention,1
Other,obesity,1
Other,observation of covid 19 pneumonia,1
Other,observation of different courses of sars-cov-2 infection in different phases (acute vs. post-acute),1
Other,observation of different courses of sars-cov-2 infection in different phases (acute vs. post-acute)/settings,1
Other,observation to monitor patients for these infections,1
Other,observational cohort study on the natural history of hospitalized sars-cov-2 patients.,1
Other,obvio-19 app,1
Other,old ppe,1
Other,olfaction testing,1
Other,olfactory,1
Other,olfactory function evaluation,1
Other,olfactory/gustatory tests,1
Other,online cognitive stimulation therapy,1
Other,optimized management of covid-19 positive kidney transplant recipients: single center experience from the middle east,1
Other,optional interview,1
Other,or antiplatelet) before admission for covid19,1
Other,or mis-c exposure,1
Other,"or psychotherapy, n=10)",1
Other,oral intervention with cetylpyridinium chloride,1
Other,oropharyngeal,1
Other,oropharyngeal/intestinal microbiota,1
Other,overnight intensive recovery,1
Other,overnight intensive recovery / extended post anaesthetic care in pacu,1
Other,oxygen mask,1
Other,pandemic control measures,1
Other,paraclinical examination,1
Other,parents during induction,1
Other,particle measurement,1
Other,passed infection of sars-cov-2,1
Other,patient characteristics,1
Other,patient quality of life assessment,1
Other,patient sampling,1
Other,patient with sar-cov-2 infection,1
Other,patients,1
Other,patients admitted in intensive care units,1
Other,patients admitted to intensive care unit with sars-cov2,1
Other,patients covid 19,1
Other,patients received standard of care treatment during hospitalization,1
Other,pcr,1
Other,pct/serology,1
Other,peep,1
Other,perceived stress scale,1
Other,personal freedom message,1
Other,personal protective equipment from biological hazard,1
Other,personal protective testing booth,1
Other,phobia questionairre,1
Other,phone call interview,1
Other,phone interview,1
Other,phone interviews,1
Other,phq,1
Other,phq-9 depression scale,1
Other,phsyiotherapy,1
Other,physical activity program,1
Other,physical therapy,1
Other,physiological effects of awake prone position in covid 19 patients,1
Other,plethysmography,1
Other,plethysmography/dlco,1
Other,poct,1
Other,post-mortem biopsies.,1
Other,post covid-19 functional satus scale,1
Other,postpartum,1
Other,postpartum anxiety scale scores,1
Other,postpartum women under investigation for coronavirus/diagnosed with covid-19,1
Other,postural positioning,1
Other,prayer,1
Other,pre-operative screening,1
Other,predict admission of covid-19 patients to icu,1
Other,"predict admission of covid-19 patients to icu/death with routine/quickly avalaible clinical, biological/radiological variables?",1
Other,prediction market,1
Other,predictive factors for clinical response in patients with covid-19.,1
Other,predictors adverse evolution,1
Other,predictors of health care provide,1
Other,pregnant women under investigation for coronavirus,1
Other,pregnant women under investigation for coronavirus/diagnosed with covid-19,1
Other,prevalence of covid-19,1
Other,preventive information,1
Other,primary care,1
Other,"primary care professionals reports of potential patient safety incidents, non-covid-19 related",1
Other,pro-sero-cov,1
Other,"pro bnp , vitamin d",1
Other,probiorinse,1
Other,produce prescription program,1
Other,progressive cycling exercise test to exhaustion,1
Other,project echo,1
Other,prolectin-m; a (1-6)-alpha-d-mannopyranose class,1
Other,prolonged proned positioning,1
Other,prone lying position,1
Other,prospective chart review,1
Other,prospective oberservational registry,1
Other,protective ventilation,1
Other,psg,1
Other,psqi,1
Other,pss,1
Other,psycho-education video,1
Other,psychoeducation,1
Other,psychoeducational intervention,1
Other,psychological,1
Other,psychological rehabilitation,1
Other,psychological/sociological interviews,1
Other,psychometric scale administration,1
Other,ptsd check list (pcl) scale,1
Other,pulmonary physiotherapy techniques,1
Other,pulmonary tele-rehabilitation,1
Other,q spect-ct,1
Other,qualitative interviews..,1
Other,quality of life promotion,1
Other,quality of life questionnaires,1
Other,quality of live assessment,1
Other,querying the insee database,1
Other,questionaire,1
Other,"questionnaire administration,blood sampling",1
Other,"questionnaire administration,blood sampling/genetic analyses.",1
Other,"questionnaire, phone call",1
Other,questionnaire/interview,1
Other,questionnaire/optional interview,1
Other,questionnaires on psychological quality of life,1
Other,"quickly avalaible clinical, biological",1
Other,radiological lung involvement evolution,1
Other,radiological variables?,1
Other,radx chcs testing intervention strategy,1
Other,"raman analysis of saliva, characterization of the raman database",1
Other,"raman analysis of saliva, characterization of the raman database/building of the classification model",1
Other,rapid-3,1
Other,rapid antibody test,1
Other,rapid molecular test,1
Other,reactivity,1
Other,regular care,1
Other,rehabilitation,1
Other,rehabilitation by concentric exercises,1
Other,rehabilitation by eccentric exercises,1
Other,rehabilitation protocol through a digital platform,1
Other,relation between frailty,1
Other,relation between frailty/clinical outcomes in elderly patients with covid-19.,1
Other,relationship scales questionnaire (rsq),1
Other,remote controlled exercise,1
Other,"remote sms (short message service, also known as ""text message"") delivery",1
Other,removal of dead space filter,1
Other,reprocessing recent traumatic event protocol,1
Other,research specific blood sample,1
Other,respiratory,1
Other,respiratory function rehabilitation training,1
Other,respiratory functions,1
Other,respiratory physiotherapy,1
Other,respiratory rehabilitation program (rr).,1
Other,respiratory tele-rehabilitation program (trr).,1
Other,respiratory training,1
Other,respiratory/psychological rehabilitation,1
Other,retrospective,1
Other,retrospective metagenomics on clinical samples collected during hospitalization,1
Other,review of medical patient file,1
Other,revised home-cov score,1
Other,risk factors,1
Other,routine care (no sars-covsts),1
Other,routine dental restorative procedures,1
Other,saline-sodium citrate (ssc) buffer,1
Other,saline with baby shampoo nasal irrigation,1
Other,saliva based assay: crude rna extraction,1
Other,sampling,1
Other,sampling by venipuncture (and eventually by nasopharyngeal swab),1
Other,sampling of oropharynx,1
Other,sampling of oropharynx/nasopharynx,1
Other,sarcopenia diagnosis,1
Other,sars-cov-2 and,1
Other,sars-cov-2 and/or mis-c exposure,1
Other,sars-cov-2 infection,1
Other,satisfaction evaluation,1
Other,sch intervention,1
Other,self-help mindfulness,1
Other,self-help mindfulness/compassion exercises,1
Other,self-interest message,1
Other,self-reported symptom collection,1
Other,self measurement with pulse oximeter,1
Other,self supportive care,1
Other,semi-directive interview,1
Other,semi-structured telephone questionnaire,1
Other,sending thorax ct video images via smartphone applications,1
Other,sensor usage,1
Other,separic-covid19 cohort,1
Other,serial seroconversion measurements in hospital employees during the covid-19 pandemic,1
Other,serology test follow-up,1
Other,seroprevalence of sars-cov-2 infection in patients with hiv infection,1
Other,serum,1
Other,serum neurofilaments as a marker of neurological damage.,1
Other,serum protein level analysis,1
Other,service of questionnaire,1
Other,settings,1
Other,severe acute respiratory syndrome coronavirus 2 detection,1
Other,severity of lung involvement with covid-19.,1
Other,sham inflation,1
Other,shanshamani vati plus,1
Other,simulation of repurposed drugs for covid-19,1
Other,singstrong: strong lungs through song,1
Other,sit-to-stand test,1
Other,six-minute walk test (6mwt),1
Other,six minutes walk test,1
Other,smartphone-based voice,1
Other,smartphone-based voice/self-reported symptom collection,1
Other,smartphone technology,1
Other,soc/placebo iv,1
Other,"sodium chloride, 0.9%",1
Other,solution-focused support program,1
Other,SOP,1
Other,specific exercise rehabilitation treatment,1
Other,specimens specific for the study,1
Other,speq (specific psychotic experiences questionnaire) - paranoia,1
Other,speq (specific psychotic experiences questionnaire) - paranoia/grandiosity subscales,1
Other,sperm collection,1
Other,spin-chat program,1
Other,spirometry,1
Other,st. george's respiratory questionnaire (sgrq),1
Other,staff wellbeing centres,1
Other,standard care/monitoring,1
Other,standard interface,1
Other,standard oxygen delivery system,1
Other,state-trait anxiety inventory scale,1
Other,steroid taper (prednisone),1
Other,stool analysis,1
Other,stp / covid-19 convalescent plasma (cp),1
Other,stp / standard plasma (sp),1
Other,stress,1
Other,stress scale,1
Other,stress/anxiety questionnaire,1
Other,study a,1
Other,study b,1
Other,study c,1
Other,study d,1
Other,sudarshan kriya yoga (sky),1
Other,supine position,1
Other,supine positioning,1
Other,support as usual,1
Other,supportive services,1
Other,supportive tratment,1
Other,surge capacity,1
Other,surge index,1
Other,"surgery: dynamic hip screw, hemiarthroplasty, hip replacement, intramedullary nail",1
Other,surgical face mask use only,1
Other,surgical facial mask,1
Other,survey/questionnaire,1
Other,surveys/questionnaires,1
Other,suspension,1
Other,suspension/maintenance of angiotensin receptor blockers/angiotensin-converting enzyme inhibitors,1
Other,swab,1
Other,sweat samples (covidog ancillary study),1
Other,symptom survey,1
Other,"symptomatology, treatment. daily activities",1
Other,symptoms,1
Other,taking biological samples,1
Other,taste/olfactory function evaluation,1
Other,teleconsultation,1
Other,teleconsultation either by phone/by computer consultation,1
Other,teleconsultation either by phone/by computer consultation. quantitative/qualitative approaches to analysis,1
Other,telegeriatric intervention,1
Other,telehealth monitoring,1
Other,telemonitoring,1
Other,telemonitoring/teleorientation,1
Other,teleorientation,1
Other,telephone consult,1
Other,telephone interview,1
Other,telestroke,1
Other,tested for sars-cov-2 (regardless of the result),1
Other,testis pathology samples,1
Other,the drugs used before,1
Other,"the drugs used before/during the pandemic, the patient's job status, physical activity conditions, pain status",1
Other,the effects of covid 19 pandemic on the cardiovascular heath of children with autism spectrum disorder,1
Other,the management of severe covid-19 cases,1
Other,the standard protocol only,1
Other,therapeutic exercise,1
Other,therapeutic exercise/education,1
Other,therapeutic plasma exchange (tpe),1
Other,there is no intervention in this study,1
Other,thoracic lung ultrasound,1
Other,thrombin,1
Other,thromboprofylaxis protocol,1
Other,to determine the prevalence of renal dysfunction in hospitalized children with covid19 in qatar.,1
Other,tr,1
Other,traditional proning arm,1
Other,training clinicians in basic critical care,1
Other,training clinicians in basic critical care/the management of severe covid-19 cases,1
Other,training load,1
Other,"training of youth, community health assistants",1
Other,"training of youth, community health assistants/community health workers.",1
Other,transplant patient,1
Other,transthoracic echocardiogram (tte),1
Other,travelan otc,1
Other,treated with hyperimmune plasma,1
Other,treatment for covid-19,1
Other,treatment group,1
Other,trust in science message,1
Other,tsu,1
Other,ultraprotective ventilation,1
Other,ultrasonography,1
Other,unsupervised physical activities,1
Other,urine collection,1
Other,urine samples,1
Other,use,1
Other,use of continuous positive airway pressure,1
Other,use of facetime with child,1
Other,use of facetime with child/parents during induction,1
Other,use of high flow nasal cannula alone,1
Other,use of non-invasive ventilation,1
Other,use/exposure to disinfectants during the coronavirus pandemic,1
Other,usual antibiotic treatment,1
Other,usual care control,1
Other,usual care only,1
Other,usual orientations,1
Other,v,1
Other,v/q spect-ct,1
Other,vaccine coverage assessment,1
Other,validation of the lamp assays,1
Other,validation of the ngs method,1
Other,validation of the poct antigen,1
Other,validation of the poct antigen/antibody tests,1
Other,vcpm,1
Other,vehicle,1
Other,vehicle / heparin along with best supportive care,1
Other,venipuncture in peripheral vein,1
Other,video-based intervention,1
Other,video dance classes,1
Other,viral sequence,1
Other,"virtual assistant first, then human coach",1
Other,virtual care at home,1
Other,vitamin d,1
Other,voice symptom scale (voiss),1
Other,walk test,1
Other,water,1
Other,water (e) mouth rinse with the solution provided,1
Other,"wearable devices, saliva samples, survey measures",1
Other,wearing surgical face mask sprayed with hypertonic saline,1
Other,web-based redcap survey,1
Other,webex physical activity program,1
Other,weekly assessment,1
Other,whoqol-bref,1
Other,woebot substance use disorder,1
Other,wofb,1
Other,zaritt burden interview,1
placebo,"""sham""-block with placebo (isotone nacl)",1
placebo,"a high-dose placebo (18-59 years) at the schedule of day 0, 28, 56",1
placebo,"a high-dose placebo (60-85 years) at the schedule of day 0, 28, 56",1
placebo,"a middle-dose placebo (18-59 years) at the schedule of day 0, 28, 56",1
placebo,"a middle-dose placebo (60-85 years) at the schedule of day 0, 28, 56",1
placebo,apremilast placebo,1
placebo,b: placebo,1
placebo,bromhexine 8 mg placebo,1
placebo,corn oil (placebo),1
placebo,cst-2: placebo,1
placebo,group a (placebo),1
placebo,group b (placebo),1
placebo,hydroxychloroquine sulfate placebo,1
placebo,injectable placebo,1
placebo,lanadelumab placebo,1
placebo,masked saline placebo,1
placebo,mw33 injection placebo,1
placebo,"patch, placebo",1
placebo,placebo-lde phase 2,1
placebo,placebo-simulation of transcranial direct current stimulation,1
placebo,placebo - phase i,1
placebo,placebo (crossover vaccination period),1
placebo,placebo (im),1
placebo,placebo (inhaled solution),1
placebo,placebo (initial vaccination period),1
placebo,placebo (iv),1
placebo,placebo (methylcellulose) capsule,1
placebo,placebo (oral tablet),1
placebo,placebo (potato starch,1
placebo,placebo (saline),1
placebo,"placebo (sodium chloride, a 0.9% solution for the preparation of dosage forms for injections)",1
placebo,placebo (standard therapy),1
placebo,"placebo (two doses), priming",1
placebo,placebo 1,1
placebo,placebo 2,1
placebo,placebo booster,1
placebo,placebo control (non-behavioral infographic),1
placebo,placebo empty capsule,1
placebo,placebo for abbv-2b04,1
placebo,placebo for abbv-47d11,1
placebo,placebo for camostat mesilate,1
placebo,placebo hydroxychloroquine,1
placebo,placebo iv,1
placebo,placebo magnesium,1
placebo,placebo nitazoxanide,1
placebo,placebo of fx06,1
placebo,placebo of nicotine transdermal patch,1
placebo,placebo oil,1
placebo,placebo patch,1
placebo,placebo ribavirin,1
placebo,placebo spray,1
placebo,placebo videos,1
placebo,placebo with remdesivir,1
placebo,rdv placebo,1
placebo,recombinant novel coronavirus vaccine (adenovirus type 5 vector) -placebo,1
placebo,saline placebo boost,1
placebo,sphenopalatine ganglion block with placebo (isotone nacl),1
placebo,"three doses of placebo at the schedule of day 0, 14, 28 #high-dose group#",1
placebo,"three doses of placebo at the schedule of day 0, 14, 28 #middle-dose group#",1
placebo,"two doses of placebo at the schedule of day 0, 14 #high-dose group#",1
placebo,"two doses of placebo at the schedule of day 0, 14 #middle-dose group#",1
placebo,zilucoplan placebo,1
Procedure,abdominal ultrasound,1
Procedure,airway management during sedation,1
Procedure,airway management during sedation/general anesthesia,1
Procedure,alveolar,1
Procedure,an69-oxiris,1
Procedure,an69-standard,1
Procedure,anesthesia management,1
Procedure,appendectomy,1
Procedure,auditory evoked potentials (aep),1
Procedure,auricular neuromodulation,1
Procedure,autopsy,1
Procedure,bariatric procedures,1
Procedure,blink,1
Procedure,blink/masseter inhibitory reflex,1
Procedure,"blood collection at day 8, day 16, day 24, month 6",1
Procedure,"blood collection at day 8, day 16, day 24, month 6/month 12 after first symptoms from sars-cov-2 infection",1
Procedure,blood draw,1
Procedure,blood test,1
Procedure,clinical examination,1
Procedure,collection of mucosal lining fluid,1
Procedure,colorectal resections,1
Procedure,continuous renal replacement therapy,1
Procedure,control,1
Procedure,conventional oxygen therapy,1
Procedure,covid icu containment measures,1
Procedure,cpap,1
Procedure,csvf,1
Procedure,ct-scan,1
Procedure,cuff application with inflation,1
Procedure,data collection: clinical care assessments,1
Procedure,elective cancer surgery,1
Procedure,emergency laparotomy,1
Procedure,emergency surgery,1
Procedure,emergency surgical procedures,1
Procedure,emergent cases,1
Procedure,endoscopic intervention,1
Procedure,endoscopic procedure,1
Procedure,evaluation of changes in the diagnostic-therapeutic pathway,1
Procedure,expanded hemodialysis for covid19 maintenance hemodialysis patients,1
Procedure,exposure surveys,1
Procedure,extracorporeal left hemicolectomy anastomosis,1
Procedure,facial fractures reduction,1
Procedure,facial fractures reduction/osteosynthesis,1
Procedure,gastric cancer surgery,1
Procedure,gastrointestinal endoscopy,1
Procedure,general anesthesia,1
Procedure,gloves,1
Procedure,hemodialysis by protein-leaking dialyzer for covid19 maintenance hemodialysis patients,1
Procedure,high flow nasal cannula,1
Procedure,hip arthropalsty,1
Procedure,intracorporeal left hemicolectomy anastomosis,1
Procedure,invasive ventilation strategy,1
Procedure,kidney biopsy,1
Procedure,laparoscopic,1
Procedure,laparoscopic appendectomy,1
Procedure,laparoscopic/open appendicectomy,1
Procedure,lateral position (left,1
Procedure,lateral position (left/right lateral decubitus),1
Procedure,"liver, lung, heart",1
Procedure,"liver, lung, heart/kidney biopsy",1
Procedure,lung ultrasound,1
Procedure,lung ultrasound (lus),1
Procedure,masseter inhibitory reflex,1
Procedure,mechanical ventilation,1
Procedure,meditation therapy,1
Procedure,mesenchymal stem cells,1
Procedure,mesenchymalÂ stem cells,1
Procedure,mitral valve surgery,1
Procedure,month 12 after first symptoms from sars-cov-2 infection,1
Procedure,mri scans,1
Procedure,muscle biopsy,1
Procedure,nasopharyngeal,1
Procedure,nasopharyngeal/throat swab,1
Procedure,non-cardiac surgery,1
Procedure,non-invasive ventilation strategies,1
Procedure,non-operative management,1
Procedure,observation for study group,1
Procedure,open appendicectomy,1
Procedure,operative management,1
Procedure,orthopaedic surgical procedures,1
Procedure,osteosynthesis,1
Procedure,ozone,1
Procedure,percutaneous treatment,1
Procedure,physical therapy,1
Procedure,plasma,1
Procedure,plasma exchange/convalescent plasma,1
Procedure,procalcitonin,1
Procedure,pulmonary rehabilitation,1
Procedure,questionnaire,1
Procedure,right lateral decubitus),1
Procedure,robot assisted percutaneous cardiovascular intervention,1
Procedure,sphenopalatine ganglion block with local anesthetic,1
Procedure,steam inhalations,1
Procedure,stellate ganglion block,1
Procedure,study arm,1
Procedure,surgery,1
Procedure,surgical procedure for cancer,1
Procedure,surgical procedures performed under general anesthesia,1
Procedure,surgical repair,1
Procedure,symptom,1
Procedure,symptom/exposure surveys,1
Procedure,telephone follow-up,1
Procedure,"the study evaluates all surgical patients operated, both elective scheduled",1
Procedure,"the study evaluates all surgical patients operated, both elective scheduled/emergent cases",1
Procedure,thyroidectomy,1
Procedure,tracheostomy,1
Procedure,tracheostomy with aerosol box in covid-19 positive patients,1
Procedure,tracheotomy,1
Procedure,tsvf,1
Procedure,yoga,1
Radiation,99mtc-pertechnetate,1
Radiation,99mtc-pertechnetate aerosol,1
Radiation,angiography scanner,1
Radiation,chest radiography,1
Radiation,high dose radiation 100 cgy,1
Radiation,lung low dose radiation,1
Radiation,radiological,1
Radiation,thoracic computed tomography scan,1
Radiation,thoracic ct-scan,1
